Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Ischemic Stroke Is Associated with the <italic>ABO</italic> Locus: The EuroCLOT Study</title><author><name sortKey="Williams, Frances M K" sort="Williams, Frances M K" uniqKey="Williams F" first="Frances M K" last="Williams">Frances M K. Williams</name><affiliation><nlm:aff id="au1"><institution>Department of Twin Research and Genetic Epidemiology, King's College London</institution><addr-line>London, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Carter, Angela M" sort="Carter, Angela M" uniqKey="Carter A" first="Angela M" last="Carter">Angela M. Carter</name><affiliation><nlm:aff id="au2"><institution>Division of Cardiovascular and Diabetes Research, University of Leeds</institution><addr-line>Leeds, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Hysi, Pirro G" sort="Hysi, Pirro G" uniqKey="Hysi P" first="Pirro G" last="Hysi">Pirro G. Hysi</name><affiliation><nlm:aff id="au1"><institution>Department of Twin Research and Genetic Epidemiology, King's College London</institution><addr-line>London, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Surdulescu, Gabriela" sort="Surdulescu, Gabriela" uniqKey="Surdulescu G" first="Gabriela" last="Surdulescu">Gabriela Surdulescu</name><affiliation><nlm:aff id="au1"><institution>Department of Twin Research and Genetic Epidemiology, King's College London</institution><addr-line>London, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Hodgkiss, Dylan" sort="Hodgkiss, Dylan" uniqKey="Hodgkiss D" first="Dylan" last="Hodgkiss">Dylan Hodgkiss</name><affiliation><nlm:aff id="au1"><institution>Department of Twin Research and Genetic Epidemiology, King's College London</institution><addr-line>London, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Soranzo, Nicole" sort="Soranzo, Nicole" uniqKey="Soranzo N" first="Nicole" last="Soranzo">Nicole Soranzo</name><affiliation><nlm:aff id="au3"><institution>Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus</institution><addr-line>Hinxton, United Kingdom</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au4"><institution>Program in Medical and Population Genetics and Genetic Analysis Platform, Broad Institute of Massachusetts Institute of Technology and Harvard</institution><addr-line>Cambridge, MA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au5"><institution>Department of Medical Genetics, University of Helsinki and University Central Hospital</institution><addr-line>Helsinki, Finland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Traylor, Matthew" sort="Traylor, Matthew" uniqKey="Traylor M" first="Matthew" last="Traylor">Matthew Traylor</name><affiliation><nlm:aff id="au6"><institution>Stroke and Dementia Research Centre, St George's University of London</institution><addr-line>London, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Bevan, Steve" sort="Bevan, Steve" uniqKey="Bevan S" first="Steve" last="Bevan">Steve Bevan</name><affiliation><nlm:aff id="au6"><institution>Stroke and Dementia Research Centre, St George's University of London</institution><addr-line>London, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Dichgans, Martin" sort="Dichgans, Martin" uniqKey="Dichgans M" first="Martin" last="Dichgans">Martin Dichgans</name><affiliation><nlm:aff id="au7"><institution>Institute for Stroke and Dementia Research, Klinikum der Universität Munich, Ludwig-Maximilians-University</institution><addr-line>Munich, Germany</addr-line></nlm:aff></affiliation></author><author><name sortKey="Rothwell, Peter M W" sort="Rothwell, Peter M W" uniqKey="Rothwell P" first="Peter M W" last="Rothwell">Peter M W. Rothwell</name><affiliation><nlm:aff id="au8"><institution>Stroke Prevention Research Unit, University Department of Clinical Neurology, Oxford University</institution><addr-line>Oxford, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Sudlow, Cathie" sort="Sudlow, Cathie" uniqKey="Sudlow C" first="Cathie" last="Sudlow">Cathie Sudlow</name><affiliation><nlm:aff id="au9"><institution>Division of Clinical Neurosciences, University of Edinburgh</institution><addr-line>Edinburgh, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Farrall, Martin" sort="Farrall, Martin" uniqKey="Farrall M" first="Martin" last="Farrall">Martin Farrall</name><affiliation><nlm:aff id="au10"><institution>Wellcome Trust Centre for Human Genetics and Department of Cardiovascular Medicine, University of Oxford</institution><addr-line>Oxford, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Silander, Kaisa" sort="Silander, Kaisa" uniqKey="Silander K" first="Kaisa" last="Silander">Kaisa Silander</name><affiliation><nlm:aff id="au11"><institution>Institute for Molecular Medicine Finland, University of Helsinki</institution><addr-line>Helsinki, Finland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Kaunisto, Mari" sort="Kaunisto, Mari" uniqKey="Kaunisto M" first="Mari" last="Kaunisto">Mari Kaunisto</name><affiliation><nlm:aff id="au11"><institution>Institute for Molecular Medicine Finland, University of Helsinki</institution><addr-line>Helsinki, Finland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Wagner, Peter" sort="Wagner, Peter" uniqKey="Wagner P" first="Peter" last="Wagner">Peter Wagner</name><affiliation><nlm:aff id="au11"><institution>Institute for Molecular Medicine Finland, University of Helsinki</institution><addr-line>Helsinki, Finland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Saarela, Olli" sort="Saarela, Olli" uniqKey="Saarela O" first="Olli" last="Saarela">Olli Saarela</name><affiliation><nlm:aff id="au12"><institution>Chronic Disease Epidemiology and Prevention Unit, National Institute for Health and Welfare</institution><addr-line>Helsinki, Finland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Kuulasmaa, Kari" sort="Kuulasmaa, Kari" uniqKey="Kuulasmaa K" first="Kari" last="Kuulasmaa">Kari Kuulasmaa</name><affiliation><nlm:aff id="au12"><institution>Chronic Disease Epidemiology and Prevention Unit, National Institute for Health and Welfare</institution><addr-line>Helsinki, Finland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Virtamo, Jarmo" sort="Virtamo, Jarmo" uniqKey="Virtamo J" first="Jarmo" last="Virtamo">Jarmo Virtamo</name><affiliation><nlm:aff id="au12"><institution>Chronic Disease Epidemiology and Prevention Unit, National Institute for Health and Welfare</institution><addr-line>Helsinki, Finland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Salomaa, Veikko" sort="Salomaa, Veikko" uniqKey="Salomaa V" first="Veikko" last="Salomaa">Veikko Salomaa</name><affiliation><nlm:aff id="au12"><institution>Chronic Disease Epidemiology and Prevention Unit, National Institute for Health and Welfare</institution><addr-line>Helsinki, Finland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Amouyel, Philippe" sort="Amouyel, Philippe" uniqKey="Amouyel P" first="Philippe" last="Amouyel">Philippe Amouyel</name><affiliation><nlm:aff id="au13"><institution>Department of Epidemiology and Public Health, Pasteur Institute of Lille</institution><addr-line>Lille, France</addr-line></nlm:aff></affiliation></author><author><name sortKey="Arveiler, Dominique" sort="Arveiler, Dominique" uniqKey="Arveiler D" first="Dominique" last="Arveiler">Dominique Arveiler</name><affiliation><nlm:aff id="au14"><institution>Department of Epidemiology and Public Health, University of Strasbourg</institution><addr-line>Strasbourg, France</addr-line></nlm:aff></affiliation></author><author><name sortKey="Ferrieres, Jean" sort="Ferrieres, Jean" uniqKey="Ferrieres J" first="Jean" last="Ferrieres">Jean Ferrieres</name><affiliation><nlm:aff id="au15"><institution>Department of Epidemiology, Faculty of Medicine</institution><addr-line>Toulouse-Purpan, Toulouse, France</addr-line></nlm:aff></affiliation></author><author><name sortKey="Wiklund, Per Gunnar" sort="Wiklund, Per Gunnar" uniqKey="Wiklund P" first="Per-Gunnar" last="Wiklund">Per-Gunnar Wiklund</name><affiliation><nlm:aff id="au16"><institution>Department of Internal Medicine, University of Umeå</institution><addr-line>Umeå, Sweden</addr-line></nlm:aff></affiliation></author><author><name sortKey="Arfan Ikram, M" sort="Arfan Ikram, M" uniqKey="Arfan Ikram M" first="M" last="Arfan Ikram">M. Arfan Ikram</name><affiliation><nlm:aff id="au17"><institution>Department of Epidemiology, Erasmus University Medical Center</institution><addr-line>Rotterdam, the Netherlands</addr-line></nlm:aff></affiliation></author><author><name sortKey="Hofman, Albert" sort="Hofman, Albert" uniqKey="Hofman A" first="Albert" last="Hofman">Albert Hofman</name><affiliation><nlm:aff id="au17"><institution>Department of Epidemiology, Erasmus University Medical Center</institution><addr-line>Rotterdam, the Netherlands</addr-line></nlm:aff></affiliation></author><author><name sortKey="Boncoraglio, Giorgio B" sort="Boncoraglio, Giorgio B" uniqKey="Boncoraglio G" first="Giorgio B" last="Boncoraglio">Giorgio B. Boncoraglio</name><affiliation><nlm:aff id="au18"><institution>Department of Neurology, Research Hospital of the Neurological Institute “Carlo Besta,”</institution><addr-line>Milan, Italy</addr-line></nlm:aff></affiliation></author><author><name sortKey="Parati, Eugenio A" sort="Parati, Eugenio A" uniqKey="Parati E" first="Eugenio A" last="Parati">Eugenio A. Parati</name><affiliation><nlm:aff id="au18"><institution>Department of Neurology, Research Hospital of the Neurological Institute “Carlo Besta,”</institution><addr-line>Milan, Italy</addr-line></nlm:aff></affiliation></author><author><name sortKey="Helgadottir, Anna" sort="Helgadottir, Anna" uniqKey="Helgadottir A" first="Anna" last="Helgadottir">Anna Helgadottir</name><affiliation><nlm:aff id="au10"><institution>Wellcome Trust Centre for Human Genetics and Department of Cardiovascular Medicine, University of Oxford</institution><addr-line>Oxford, United Kingdom</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au19"><institution>DeCODE Genetics</institution><addr-line>Reykjavik, Iceland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Gretarsdottir, Solveig" sort="Gretarsdottir, Solveig" uniqKey="Gretarsdottir S" first="Solveig" last="Gretarsdottir">Solveig Gretarsdottir</name><affiliation><nlm:aff id="au19"><institution>DeCODE Genetics</institution><addr-line>Reykjavik, Iceland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Thorsteinsdottir, Unnur" sort="Thorsteinsdottir, Unnur" uniqKey="Thorsteinsdottir U" first="Unnur" last="Thorsteinsdottir">Unnur Thorsteinsdottir</name><affiliation><nlm:aff id="au19"><institution>DeCODE Genetics</institution><addr-line>Reykjavik, Iceland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Thorleifsson, Gudmar" sort="Thorleifsson, Gudmar" uniqKey="Thorleifsson G" first="Gudmar" last="Thorleifsson">Gudmar Thorleifsson</name><affiliation><nlm:aff id="au19"><institution>DeCODE Genetics</institution><addr-line>Reykjavik, Iceland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Stefansson, Kari" sort="Stefansson, Kari" uniqKey="Stefansson K" first="Kari" last="Stefansson">Kari Stefansson</name><affiliation><nlm:aff id="au19"><institution>DeCODE Genetics</institution><addr-line>Reykjavik, Iceland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Seshadri, Sudha" sort="Seshadri, Sudha" uniqKey="Seshadri S" first="Sudha" last="Seshadri">Sudha Seshadri</name><affiliation><nlm:aff id="au20"><institution>Boston University Schools of Medicine and Public Health</institution><addr-line>Boston, MA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au21"><institution>Framingham Heart Study</institution><addr-line>Framingham, MA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au22"><institution>Departments of Health Services, University of Washington</institution><addr-line>Seattlem WA</addr-line></nlm:aff></affiliation></author><author><name sortKey="Destefano, Anita" sort="Destefano, Anita" uniqKey="Destefano A" first="Anita" last="Destefano">Anita Destefano</name><affiliation><nlm:aff id="au20"><institution>Boston University Schools of Medicine and Public Health</institution><addr-line>Boston, MA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au21"><institution>Framingham Heart Study</institution><addr-line>Framingham, MA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au22"><institution>Departments of Health Services, University of Washington</institution><addr-line>Seattlem WA</addr-line></nlm:aff></affiliation></author><author><name sortKey="Gschwendtner, Andreas" sort="Gschwendtner, Andreas" uniqKey="Gschwendtner A" first="Andreas" last="Gschwendtner">Andreas Gschwendtner</name><affiliation><nlm:aff id="au7"><institution>Institute for Stroke and Dementia Research, Klinikum der Universität Munich, Ludwig-Maximilians-University</institution><addr-line>Munich, Germany</addr-line></nlm:aff></affiliation></author><author><name sortKey="Psaty, Bruce" sort="Psaty, Bruce" uniqKey="Psaty B" first="Bruce" last="Psaty">Bruce Psaty</name><affiliation><nlm:aff id="au23"><institution>Epidemiology, Health Services, University of Washington</institution><addr-line>Seattle, WA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au24"><institution>Medicine, and Health Services, University of Washington</institution><addr-line>Seattle, WA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au25"><institution>Group Health Research Institute, Group Health</institution><addr-line>Seattle, WA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au26"><institution>Department of Neurology, University of Washington</institution><addr-line>WA</addr-line></nlm:aff></affiliation></author><author><name sortKey="Longstreth, Will" sort="Longstreth, Will" uniqKey="Longstreth W" first="Will" last="Longstreth">Will Longstreth</name><affiliation><nlm:aff id="au23"><institution>Epidemiology, Health Services, University of Washington</institution><addr-line>Seattle, WA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au24"><institution>Medicine, and Health Services, University of Washington</institution><addr-line>Seattle, WA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au27"><institution>Department of Medicine, University of Maryland</institution><addr-line>Baltimore, MD</addr-line></nlm:aff></affiliation></author><author><name sortKey="Mitchell, Braxton D" sort="Mitchell, Braxton D" uniqKey="Mitchell B" first="Braxton D" last="Mitchell">Braxton D. Mitchell</name><affiliation><nlm:aff id="au28"><institution>Clinical Trial Service Unit, University of Oxford</institution><addr-line>Oxford, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Cheng, Yu Ching" sort="Cheng, Yu Ching" uniqKey="Cheng Y" first="Yu-Ching" last="Cheng">Yu-Ching Cheng</name><affiliation><nlm:aff id="au28"><institution>Clinical Trial Service Unit, University of Oxford</institution><addr-line>Oxford, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Clarke, Robert" sort="Clarke, Robert" uniqKey="Clarke R" first="Robert" last="Clarke">Robert Clarke</name><affiliation><nlm:aff id="au29"><institution>University of Insubria</institution><addr-line>Varese, Italy</addr-line></nlm:aff></affiliation></author><author><name sortKey="Ferrario, Marco" sort="Ferrario, Marco" uniqKey="Ferrario M" first="Marco" last="Ferrario">Marco Ferrario</name><affiliation><nlm:aff id="au30"><institution>Cardiovascular Health Research Unit, Department of Medicine, University of Washington</institution><addr-line>Seattle, WA</addr-line></nlm:aff></affiliation></author><author><name sortKey="Bis, Joshua C" sort="Bis, Joshua C" uniqKey="Bis J" first="Joshua C" last="Bis">Joshua C. Bis</name><affiliation><nlm:aff id="au31"><institution>University of Newcastle</institution><addr-line>Callaghan, Australia</addr-line></nlm:aff></affiliation></author><author><name sortKey="Levi, Christopher" sort="Levi, Christopher" uniqKey="Levi C" first="Christopher" last="Levi">Christopher Levi</name><affiliation><nlm:aff id="au32"><institution>John Hunter Hospital</institution><addr-line>New Lambton Heights, Australia</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au33"><institution>Hunter Medical Research Institute</institution><addr-line>New Lambton, Australia</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au34"><institution>Human Genetics Center and Institute of Molecular Medicine, University of Texas Health Sciences Center</institution><addr-line>Houston, TX</addr-line></nlm:aff></affiliation></author><author><name sortKey="Attia, John" sort="Attia, John" uniqKey="Attia J" first="John" last="Attia">John Attia</name><affiliation><nlm:aff id="au32"><institution>John Hunter Hospital</institution><addr-line>New Lambton Heights, Australia</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au33"><institution>Hunter Medical Research Institute</institution><addr-line>New Lambton, Australia</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au34"><institution>Human Genetics Center and Institute of Molecular Medicine, University of Texas Health Sciences Center</institution><addr-line>Houston, TX</addr-line></nlm:aff></affiliation></author><author><name sortKey="Holliday, Elizabeth G" sort="Holliday, Elizabeth G" uniqKey="Holliday E" first="Elizabeth G" last="Holliday">Elizabeth G. Holliday</name><affiliation><nlm:aff id="au32"><institution>John Hunter Hospital</institution><addr-line>New Lambton Heights, Australia</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au33"><institution>Hunter Medical Research Institute</institution><addr-line>New Lambton, Australia</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au34"><institution>Human Genetics Center and Institute of Molecular Medicine, University of Texas Health Sciences Center</institution><addr-line>Houston, TX</addr-line></nlm:aff></affiliation></author><author><name sortKey="Scott, Rodney J" sort="Scott, Rodney J" uniqKey="Scott R" first="Rodney J" last="Scott">Rodney J. Scott</name><affiliation><nlm:aff id="au32"><institution>John Hunter Hospital</institution><addr-line>New Lambton Heights, Australia</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au33"><institution>Hunter Medical Research Institute</institution><addr-line>New Lambton, Australia</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au34"><institution>Human Genetics Center and Institute of Molecular Medicine, University of Texas Health Sciences Center</institution><addr-line>Houston, TX</addr-line></nlm:aff></affiliation></author><author><name sortKey="Fornage, Myriam" sort="Fornage, Myriam" uniqKey="Fornage M" first="Myriam" last="Fornage">Myriam Fornage</name><affiliation><nlm:aff id="au35"><institution>Imperial College Cerebrovascular Research Unit, Imperial College London</institution><addr-line>London, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Sharma, Pankaj" sort="Sharma, Pankaj" uniqKey="Sharma P" first="Pankaj" last="Sharma">Pankaj Sharma</name><affiliation><nlm:aff id="au36"><institution>Center for Human Genetic Research, Massachusetts General Hospital and Harvard Medical School</institution><addr-line>Boston, MA</addr-line></nlm:aff></affiliation></author><author><name sortKey="Furie, Karen L" sort="Furie, Karen L" uniqKey="Furie K" first="Karen L" last="Furie">Karen L. Furie</name><affiliation><nlm:aff id="au37"><institution>Department of Neurology, Mayo Clinic</institution><addr-line>Jacksonville, FL, USA</addr-line></nlm:aff></affiliation></author><author><name sortKey="Rosand, Jonathan" sort="Rosand, Jonathan" uniqKey="Rosand J" first="Jonathan" last="Rosand">Jonathan Rosand</name><affiliation><nlm:aff id="au37"><institution>Department of Neurology, Mayo Clinic</institution><addr-line>Jacksonville, FL, USA</addr-line></nlm:aff></affiliation></author><author><name sortKey="Nalls, Mike" sort="Nalls, Mike" uniqKey="Nalls M" first="Mike" last="Nalls">Mike Nalls</name><affiliation><nlm:aff id="au38"><institution>University of Mississippi Medical Center</institution><addr-line>Jackson, MS</addr-line></nlm:aff></affiliation></author><author><name sortKey="Meschia, James" sort="Meschia, James" uniqKey="Meschia J" first="James" last="Meschia">James Meschia</name><affiliation><nlm:aff id="au38"><institution>University of Mississippi Medical Center</institution><addr-line>Jackson, MS</addr-line></nlm:aff></affiliation></author><author><name sortKey="Mosely, Thomas H" sort="Mosely, Thomas H" uniqKey="Mosely T" first="Thomas H" last="Mosely">Thomas H. Mosely</name><affiliation><nlm:aff id="au39"><institution>Queen's University of Belfast</institution><addr-line>Belfast, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Evans, Alun" sort="Evans, Alun" uniqKey="Evans A" first="Alun" last="Evans">Alun Evans</name></author><author><name sortKey="Palotie, Aarno" sort="Palotie, Aarno" uniqKey="Palotie A" first="Aarno" last="Palotie">Aarno Palotie</name><affiliation><nlm:aff id="au3"><institution>Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus</institution><addr-line>Hinxton, United Kingdom</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au4"><institution>Program in Medical and Population Genetics and Genetic Analysis Platform, Broad Institute of Massachusetts Institute of Technology and Harvard</institution><addr-line>Cambridge, MA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au5"><institution>Department of Medical Genetics, University of Helsinki and University Central Hospital</institution><addr-line>Helsinki, Finland</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au11"><institution>Institute for Molecular Medicine Finland, University of Helsinki</institution><addr-line>Helsinki, Finland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Markus, Hugh S" sort="Markus, Hugh S" uniqKey="Markus H" first="Hugh S" last="Markus">Hugh S. Markus</name><affiliation><nlm:aff id="au6"><institution>Stroke and Dementia Research Centre, St George's University of London</institution><addr-line>London, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Grant, Peter J" sort="Grant, Peter J" uniqKey="Grant P" first="Peter J" last="Grant">Peter J. Grant</name><affiliation><nlm:aff id="au2"><institution>Division of Cardiovascular and Diabetes Research, University of Leeds</institution><addr-line>Leeds, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Spector, Tim D" sort="Spector, Tim D" uniqKey="Spector T" first="Tim D" last="Spector">Tim D. Spector</name><affiliation><nlm:aff id="au1"><institution>Department of Twin Research and Genetic Epidemiology, King's College London</institution><addr-line>London, United Kingdom</addr-line></nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">23381943</idno><idno type="pmc">3582024</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582024</idno><idno type="RBID">PMC:3582024</idno><idno type="doi">10.1002/ana.23838</idno><date when="2013">2013</date><idno type="wicri:Area/Pmc/Corpus">002239</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002239</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Ischemic Stroke Is Associated with the <italic>ABO</italic> Locus: The EuroCLOT Study</title><author><name sortKey="Williams, Frances M K" sort="Williams, Frances M K" uniqKey="Williams F" first="Frances M K" last="Williams">Frances M K. Williams</name><affiliation><nlm:aff id="au1"><institution>Department of Twin Research and Genetic Epidemiology, King's College London</institution><addr-line>London, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Carter, Angela M" sort="Carter, Angela M" uniqKey="Carter A" first="Angela M" last="Carter">Angela M. Carter</name><affiliation><nlm:aff id="au2"><institution>Division of Cardiovascular and Diabetes Research, University of Leeds</institution><addr-line>Leeds, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Hysi, Pirro G" sort="Hysi, Pirro G" uniqKey="Hysi P" first="Pirro G" last="Hysi">Pirro G. Hysi</name><affiliation><nlm:aff id="au1"><institution>Department of Twin Research and Genetic Epidemiology, King's College London</institution><addr-line>London, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Surdulescu, Gabriela" sort="Surdulescu, Gabriela" uniqKey="Surdulescu G" first="Gabriela" last="Surdulescu">Gabriela Surdulescu</name><affiliation><nlm:aff id="au1"><institution>Department of Twin Research and Genetic Epidemiology, King's College London</institution><addr-line>London, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Hodgkiss, Dylan" sort="Hodgkiss, Dylan" uniqKey="Hodgkiss D" first="Dylan" last="Hodgkiss">Dylan Hodgkiss</name><affiliation><nlm:aff id="au1"><institution>Department of Twin Research and Genetic Epidemiology, King's College London</institution><addr-line>London, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Soranzo, Nicole" sort="Soranzo, Nicole" uniqKey="Soranzo N" first="Nicole" last="Soranzo">Nicole Soranzo</name><affiliation><nlm:aff id="au3"><institution>Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus</institution><addr-line>Hinxton, United Kingdom</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au4"><institution>Program in Medical and Population Genetics and Genetic Analysis Platform, Broad Institute of Massachusetts Institute of Technology and Harvard</institution><addr-line>Cambridge, MA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au5"><institution>Department of Medical Genetics, University of Helsinki and University Central Hospital</institution><addr-line>Helsinki, Finland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Traylor, Matthew" sort="Traylor, Matthew" uniqKey="Traylor M" first="Matthew" last="Traylor">Matthew Traylor</name><affiliation><nlm:aff id="au6"><institution>Stroke and Dementia Research Centre, St George's University of London</institution><addr-line>London, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Bevan, Steve" sort="Bevan, Steve" uniqKey="Bevan S" first="Steve" last="Bevan">Steve Bevan</name><affiliation><nlm:aff id="au6"><institution>Stroke and Dementia Research Centre, St George's University of London</institution><addr-line>London, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Dichgans, Martin" sort="Dichgans, Martin" uniqKey="Dichgans M" first="Martin" last="Dichgans">Martin Dichgans</name><affiliation><nlm:aff id="au7"><institution>Institute for Stroke and Dementia Research, Klinikum der Universität Munich, Ludwig-Maximilians-University</institution><addr-line>Munich, Germany</addr-line></nlm:aff></affiliation></author><author><name sortKey="Rothwell, Peter M W" sort="Rothwell, Peter M W" uniqKey="Rothwell P" first="Peter M W" last="Rothwell">Peter M W. Rothwell</name><affiliation><nlm:aff id="au8"><institution>Stroke Prevention Research Unit, University Department of Clinical Neurology, Oxford University</institution><addr-line>Oxford, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Sudlow, Cathie" sort="Sudlow, Cathie" uniqKey="Sudlow C" first="Cathie" last="Sudlow">Cathie Sudlow</name><affiliation><nlm:aff id="au9"><institution>Division of Clinical Neurosciences, University of Edinburgh</institution><addr-line>Edinburgh, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Farrall, Martin" sort="Farrall, Martin" uniqKey="Farrall M" first="Martin" last="Farrall">Martin Farrall</name><affiliation><nlm:aff id="au10"><institution>Wellcome Trust Centre for Human Genetics and Department of Cardiovascular Medicine, University of Oxford</institution><addr-line>Oxford, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Silander, Kaisa" sort="Silander, Kaisa" uniqKey="Silander K" first="Kaisa" last="Silander">Kaisa Silander</name><affiliation><nlm:aff id="au11"><institution>Institute for Molecular Medicine Finland, University of Helsinki</institution><addr-line>Helsinki, Finland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Kaunisto, Mari" sort="Kaunisto, Mari" uniqKey="Kaunisto M" first="Mari" last="Kaunisto">Mari Kaunisto</name><affiliation><nlm:aff id="au11"><institution>Institute for Molecular Medicine Finland, University of Helsinki</institution><addr-line>Helsinki, Finland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Wagner, Peter" sort="Wagner, Peter" uniqKey="Wagner P" first="Peter" last="Wagner">Peter Wagner</name><affiliation><nlm:aff id="au11"><institution>Institute for Molecular Medicine Finland, University of Helsinki</institution><addr-line>Helsinki, Finland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Saarela, Olli" sort="Saarela, Olli" uniqKey="Saarela O" first="Olli" last="Saarela">Olli Saarela</name><affiliation><nlm:aff id="au12"><institution>Chronic Disease Epidemiology and Prevention Unit, National Institute for Health and Welfare</institution><addr-line>Helsinki, Finland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Kuulasmaa, Kari" sort="Kuulasmaa, Kari" uniqKey="Kuulasmaa K" first="Kari" last="Kuulasmaa">Kari Kuulasmaa</name><affiliation><nlm:aff id="au12"><institution>Chronic Disease Epidemiology and Prevention Unit, National Institute for Health and Welfare</institution><addr-line>Helsinki, Finland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Virtamo, Jarmo" sort="Virtamo, Jarmo" uniqKey="Virtamo J" first="Jarmo" last="Virtamo">Jarmo Virtamo</name><affiliation><nlm:aff id="au12"><institution>Chronic Disease Epidemiology and Prevention Unit, National Institute for Health and Welfare</institution><addr-line>Helsinki, Finland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Salomaa, Veikko" sort="Salomaa, Veikko" uniqKey="Salomaa V" first="Veikko" last="Salomaa">Veikko Salomaa</name><affiliation><nlm:aff id="au12"><institution>Chronic Disease Epidemiology and Prevention Unit, National Institute for Health and Welfare</institution><addr-line>Helsinki, Finland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Amouyel, Philippe" sort="Amouyel, Philippe" uniqKey="Amouyel P" first="Philippe" last="Amouyel">Philippe Amouyel</name><affiliation><nlm:aff id="au13"><institution>Department of Epidemiology and Public Health, Pasteur Institute of Lille</institution><addr-line>Lille, France</addr-line></nlm:aff></affiliation></author><author><name sortKey="Arveiler, Dominique" sort="Arveiler, Dominique" uniqKey="Arveiler D" first="Dominique" last="Arveiler">Dominique Arveiler</name><affiliation><nlm:aff id="au14"><institution>Department of Epidemiology and Public Health, University of Strasbourg</institution><addr-line>Strasbourg, France</addr-line></nlm:aff></affiliation></author><author><name sortKey="Ferrieres, Jean" sort="Ferrieres, Jean" uniqKey="Ferrieres J" first="Jean" last="Ferrieres">Jean Ferrieres</name><affiliation><nlm:aff id="au15"><institution>Department of Epidemiology, Faculty of Medicine</institution><addr-line>Toulouse-Purpan, Toulouse, France</addr-line></nlm:aff></affiliation></author><author><name sortKey="Wiklund, Per Gunnar" sort="Wiklund, Per Gunnar" uniqKey="Wiklund P" first="Per-Gunnar" last="Wiklund">Per-Gunnar Wiklund</name><affiliation><nlm:aff id="au16"><institution>Department of Internal Medicine, University of Umeå</institution><addr-line>Umeå, Sweden</addr-line></nlm:aff></affiliation></author><author><name sortKey="Arfan Ikram, M" sort="Arfan Ikram, M" uniqKey="Arfan Ikram M" first="M" last="Arfan Ikram">M. Arfan Ikram</name><affiliation><nlm:aff id="au17"><institution>Department of Epidemiology, Erasmus University Medical Center</institution><addr-line>Rotterdam, the Netherlands</addr-line></nlm:aff></affiliation></author><author><name sortKey="Hofman, Albert" sort="Hofman, Albert" uniqKey="Hofman A" first="Albert" last="Hofman">Albert Hofman</name><affiliation><nlm:aff id="au17"><institution>Department of Epidemiology, Erasmus University Medical Center</institution><addr-line>Rotterdam, the Netherlands</addr-line></nlm:aff></affiliation></author><author><name sortKey="Boncoraglio, Giorgio B" sort="Boncoraglio, Giorgio B" uniqKey="Boncoraglio G" first="Giorgio B" last="Boncoraglio">Giorgio B. Boncoraglio</name><affiliation><nlm:aff id="au18"><institution>Department of Neurology, Research Hospital of the Neurological Institute “Carlo Besta,”</institution><addr-line>Milan, Italy</addr-line></nlm:aff></affiliation></author><author><name sortKey="Parati, Eugenio A" sort="Parati, Eugenio A" uniqKey="Parati E" first="Eugenio A" last="Parati">Eugenio A. Parati</name><affiliation><nlm:aff id="au18"><institution>Department of Neurology, Research Hospital of the Neurological Institute “Carlo Besta,”</institution><addr-line>Milan, Italy</addr-line></nlm:aff></affiliation></author><author><name sortKey="Helgadottir, Anna" sort="Helgadottir, Anna" uniqKey="Helgadottir A" first="Anna" last="Helgadottir">Anna Helgadottir</name><affiliation><nlm:aff id="au10"><institution>Wellcome Trust Centre for Human Genetics and Department of Cardiovascular Medicine, University of Oxford</institution><addr-line>Oxford, United Kingdom</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au19"><institution>DeCODE Genetics</institution><addr-line>Reykjavik, Iceland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Gretarsdottir, Solveig" sort="Gretarsdottir, Solveig" uniqKey="Gretarsdottir S" first="Solveig" last="Gretarsdottir">Solveig Gretarsdottir</name><affiliation><nlm:aff id="au19"><institution>DeCODE Genetics</institution><addr-line>Reykjavik, Iceland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Thorsteinsdottir, Unnur" sort="Thorsteinsdottir, Unnur" uniqKey="Thorsteinsdottir U" first="Unnur" last="Thorsteinsdottir">Unnur Thorsteinsdottir</name><affiliation><nlm:aff id="au19"><institution>DeCODE Genetics</institution><addr-line>Reykjavik, Iceland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Thorleifsson, Gudmar" sort="Thorleifsson, Gudmar" uniqKey="Thorleifsson G" first="Gudmar" last="Thorleifsson">Gudmar Thorleifsson</name><affiliation><nlm:aff id="au19"><institution>DeCODE Genetics</institution><addr-line>Reykjavik, Iceland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Stefansson, Kari" sort="Stefansson, Kari" uniqKey="Stefansson K" first="Kari" last="Stefansson">Kari Stefansson</name><affiliation><nlm:aff id="au19"><institution>DeCODE Genetics</institution><addr-line>Reykjavik, Iceland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Seshadri, Sudha" sort="Seshadri, Sudha" uniqKey="Seshadri S" first="Sudha" last="Seshadri">Sudha Seshadri</name><affiliation><nlm:aff id="au20"><institution>Boston University Schools of Medicine and Public Health</institution><addr-line>Boston, MA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au21"><institution>Framingham Heart Study</institution><addr-line>Framingham, MA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au22"><institution>Departments of Health Services, University of Washington</institution><addr-line>Seattlem WA</addr-line></nlm:aff></affiliation></author><author><name sortKey="Destefano, Anita" sort="Destefano, Anita" uniqKey="Destefano A" first="Anita" last="Destefano">Anita Destefano</name><affiliation><nlm:aff id="au20"><institution>Boston University Schools of Medicine and Public Health</institution><addr-line>Boston, MA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au21"><institution>Framingham Heart Study</institution><addr-line>Framingham, MA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au22"><institution>Departments of Health Services, University of Washington</institution><addr-line>Seattlem WA</addr-line></nlm:aff></affiliation></author><author><name sortKey="Gschwendtner, Andreas" sort="Gschwendtner, Andreas" uniqKey="Gschwendtner A" first="Andreas" last="Gschwendtner">Andreas Gschwendtner</name><affiliation><nlm:aff id="au7"><institution>Institute for Stroke and Dementia Research, Klinikum der Universität Munich, Ludwig-Maximilians-University</institution><addr-line>Munich, Germany</addr-line></nlm:aff></affiliation></author><author><name sortKey="Psaty, Bruce" sort="Psaty, Bruce" uniqKey="Psaty B" first="Bruce" last="Psaty">Bruce Psaty</name><affiliation><nlm:aff id="au23"><institution>Epidemiology, Health Services, University of Washington</institution><addr-line>Seattle, WA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au24"><institution>Medicine, and Health Services, University of Washington</institution><addr-line>Seattle, WA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au25"><institution>Group Health Research Institute, Group Health</institution><addr-line>Seattle, WA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au26"><institution>Department of Neurology, University of Washington</institution><addr-line>WA</addr-line></nlm:aff></affiliation></author><author><name sortKey="Longstreth, Will" sort="Longstreth, Will" uniqKey="Longstreth W" first="Will" last="Longstreth">Will Longstreth</name><affiliation><nlm:aff id="au23"><institution>Epidemiology, Health Services, University of Washington</institution><addr-line>Seattle, WA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au24"><institution>Medicine, and Health Services, University of Washington</institution><addr-line>Seattle, WA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au27"><institution>Department of Medicine, University of Maryland</institution><addr-line>Baltimore, MD</addr-line></nlm:aff></affiliation></author><author><name sortKey="Mitchell, Braxton D" sort="Mitchell, Braxton D" uniqKey="Mitchell B" first="Braxton D" last="Mitchell">Braxton D. Mitchell</name><affiliation><nlm:aff id="au28"><institution>Clinical Trial Service Unit, University of Oxford</institution><addr-line>Oxford, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Cheng, Yu Ching" sort="Cheng, Yu Ching" uniqKey="Cheng Y" first="Yu-Ching" last="Cheng">Yu-Ching Cheng</name><affiliation><nlm:aff id="au28"><institution>Clinical Trial Service Unit, University of Oxford</institution><addr-line>Oxford, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Clarke, Robert" sort="Clarke, Robert" uniqKey="Clarke R" first="Robert" last="Clarke">Robert Clarke</name><affiliation><nlm:aff id="au29"><institution>University of Insubria</institution><addr-line>Varese, Italy</addr-line></nlm:aff></affiliation></author><author><name sortKey="Ferrario, Marco" sort="Ferrario, Marco" uniqKey="Ferrario M" first="Marco" last="Ferrario">Marco Ferrario</name><affiliation><nlm:aff id="au30"><institution>Cardiovascular Health Research Unit, Department of Medicine, University of Washington</institution><addr-line>Seattle, WA</addr-line></nlm:aff></affiliation></author><author><name sortKey="Bis, Joshua C" sort="Bis, Joshua C" uniqKey="Bis J" first="Joshua C" last="Bis">Joshua C. Bis</name><affiliation><nlm:aff id="au31"><institution>University of Newcastle</institution><addr-line>Callaghan, Australia</addr-line></nlm:aff></affiliation></author><author><name sortKey="Levi, Christopher" sort="Levi, Christopher" uniqKey="Levi C" first="Christopher" last="Levi">Christopher Levi</name><affiliation><nlm:aff id="au32"><institution>John Hunter Hospital</institution><addr-line>New Lambton Heights, Australia</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au33"><institution>Hunter Medical Research Institute</institution><addr-line>New Lambton, Australia</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au34"><institution>Human Genetics Center and Institute of Molecular Medicine, University of Texas Health Sciences Center</institution><addr-line>Houston, TX</addr-line></nlm:aff></affiliation></author><author><name sortKey="Attia, John" sort="Attia, John" uniqKey="Attia J" first="John" last="Attia">John Attia</name><affiliation><nlm:aff id="au32"><institution>John Hunter Hospital</institution><addr-line>New Lambton Heights, Australia</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au33"><institution>Hunter Medical Research Institute</institution><addr-line>New Lambton, Australia</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au34"><institution>Human Genetics Center and Institute of Molecular Medicine, University of Texas Health Sciences Center</institution><addr-line>Houston, TX</addr-line></nlm:aff></affiliation></author><author><name sortKey="Holliday, Elizabeth G" sort="Holliday, Elizabeth G" uniqKey="Holliday E" first="Elizabeth G" last="Holliday">Elizabeth G. Holliday</name><affiliation><nlm:aff id="au32"><institution>John Hunter Hospital</institution><addr-line>New Lambton Heights, Australia</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au33"><institution>Hunter Medical Research Institute</institution><addr-line>New Lambton, Australia</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au34"><institution>Human Genetics Center and Institute of Molecular Medicine, University of Texas Health Sciences Center</institution><addr-line>Houston, TX</addr-line></nlm:aff></affiliation></author><author><name sortKey="Scott, Rodney J" sort="Scott, Rodney J" uniqKey="Scott R" first="Rodney J" last="Scott">Rodney J. Scott</name><affiliation><nlm:aff id="au32"><institution>John Hunter Hospital</institution><addr-line>New Lambton Heights, Australia</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au33"><institution>Hunter Medical Research Institute</institution><addr-line>New Lambton, Australia</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au34"><institution>Human Genetics Center and Institute of Molecular Medicine, University of Texas Health Sciences Center</institution><addr-line>Houston, TX</addr-line></nlm:aff></affiliation></author><author><name sortKey="Fornage, Myriam" sort="Fornage, Myriam" uniqKey="Fornage M" first="Myriam" last="Fornage">Myriam Fornage</name><affiliation><nlm:aff id="au35"><institution>Imperial College Cerebrovascular Research Unit, Imperial College London</institution><addr-line>London, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Sharma, Pankaj" sort="Sharma, Pankaj" uniqKey="Sharma P" first="Pankaj" last="Sharma">Pankaj Sharma</name><affiliation><nlm:aff id="au36"><institution>Center for Human Genetic Research, Massachusetts General Hospital and Harvard Medical School</institution><addr-line>Boston, MA</addr-line></nlm:aff></affiliation></author><author><name sortKey="Furie, Karen L" sort="Furie, Karen L" uniqKey="Furie K" first="Karen L" last="Furie">Karen L. Furie</name><affiliation><nlm:aff id="au37"><institution>Department of Neurology, Mayo Clinic</institution><addr-line>Jacksonville, FL, USA</addr-line></nlm:aff></affiliation></author><author><name sortKey="Rosand, Jonathan" sort="Rosand, Jonathan" uniqKey="Rosand J" first="Jonathan" last="Rosand">Jonathan Rosand</name><affiliation><nlm:aff id="au37"><institution>Department of Neurology, Mayo Clinic</institution><addr-line>Jacksonville, FL, USA</addr-line></nlm:aff></affiliation></author><author><name sortKey="Nalls, Mike" sort="Nalls, Mike" uniqKey="Nalls M" first="Mike" last="Nalls">Mike Nalls</name><affiliation><nlm:aff id="au38"><institution>University of Mississippi Medical Center</institution><addr-line>Jackson, MS</addr-line></nlm:aff></affiliation></author><author><name sortKey="Meschia, James" sort="Meschia, James" uniqKey="Meschia J" first="James" last="Meschia">James Meschia</name><affiliation><nlm:aff id="au38"><institution>University of Mississippi Medical Center</institution><addr-line>Jackson, MS</addr-line></nlm:aff></affiliation></author><author><name sortKey="Mosely, Thomas H" sort="Mosely, Thomas H" uniqKey="Mosely T" first="Thomas H" last="Mosely">Thomas H. Mosely</name><affiliation><nlm:aff id="au39"><institution>Queen's University of Belfast</institution><addr-line>Belfast, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Evans, Alun" sort="Evans, Alun" uniqKey="Evans A" first="Alun" last="Evans">Alun Evans</name></author><author><name sortKey="Palotie, Aarno" sort="Palotie, Aarno" uniqKey="Palotie A" first="Aarno" last="Palotie">Aarno Palotie</name><affiliation><nlm:aff id="au3"><institution>Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus</institution><addr-line>Hinxton, United Kingdom</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au4"><institution>Program in Medical and Population Genetics and Genetic Analysis Platform, Broad Institute of Massachusetts Institute of Technology and Harvard</institution><addr-line>Cambridge, MA</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au5"><institution>Department of Medical Genetics, University of Helsinki and University Central Hospital</institution><addr-line>Helsinki, Finland</addr-line></nlm:aff></affiliation><affiliation><nlm:aff id="au11"><institution>Institute for Molecular Medicine Finland, University of Helsinki</institution><addr-line>Helsinki, Finland</addr-line></nlm:aff></affiliation></author><author><name sortKey="Markus, Hugh S" sort="Markus, Hugh S" uniqKey="Markus H" first="Hugh S" last="Markus">Hugh S. Markus</name><affiliation><nlm:aff id="au6"><institution>Stroke and Dementia Research Centre, St George's University of London</institution><addr-line>London, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Grant, Peter J" sort="Grant, Peter J" uniqKey="Grant P" first="Peter J" last="Grant">Peter J. Grant</name><affiliation><nlm:aff id="au2"><institution>Division of Cardiovascular and Diabetes Research, University of Leeds</institution><addr-line>Leeds, United Kingdom</addr-line></nlm:aff></affiliation></author><author><name sortKey="Spector, Tim D" sort="Spector, Tim D" uniqKey="Spector T" first="Tim D" last="Spector">Tim D. Spector</name><affiliation><nlm:aff id="au1"><institution>Department of Twin Research and Genetic Epidemiology, King's College London</institution><addr-line>London, United Kingdom</addr-line></nlm:aff></affiliation></author></analytic><series><title level="j">Annals of Neurology</title><idno type="ISSN">0364-5134</idno><idno type="eISSN">1531-8249</idno><imprint><date when="2013">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec><title>Objective</title><p>End-stage coagulation and the structure/function of fibrin are implicated in the pathogenesis of ischemic stroke. We explored whether genetic variants associated with end-stage coagulation in healthy REFVIDunteers account for the genetic predisposition to ischemic stroke and examined their influence on stroke subtype.</p></sec><sec><title>Methods</title><p>Common genetic variants identified through genome-wide association studies of coagulation factors and fibrin structure/function in healthy twins (n = 2,100, Stage 1) were examined in ischemic stroke (n = 4,200 cases) using 2 independent samples of European ancestry (Stage 2). A third clinical collection having stroke subtyping (total 8,900 cases, 55,000 controls) was used for replication (Stage 3).</p></sec><sec><title>Results</title><p>Stage 1 identified 524 single nucleotide polymorphisms (SNPs) from 23 linkage disequilibrium blocks having significant association (<italic>p</italic> < 5 × 10<sup>–8</sup>) with 1 or more coagulation/fibrin phenotypes. The most striking associations included SNP rs5985 with factor XIII activity (<italic>p</italic> = 2.6 × 10<sup>–186</sup>), rs10665 with FVII (<italic>p</italic> = 2.4 × 10<sup>–47</sup>), and rs505922 in the <italic>ABO</italic> gene with both von Willebrand factor (<italic>p</italic> = 4.7 × 10<sup>–57</sup>) and factor VIII (<italic>p</italic> = 1.2 × 10<sup>–36</sup>). In Stage 2, the 23 independent SNPs were examined in stroke cases/noncases using MOnica Risk, Genetics, Archiving and Monograph (MORGAM) and Wellcome Trust Case Control Consortium 2 collections. SNP rs505922 was nominally associated with ischemic stroke (odds ratio = 0.94, 95% confidence interval = 0.88–0.99, <italic>p</italic> = 0.023). Independent replication in Meta-Stroke confirmed the rs505922 association with stroke, beta (standard error, SE) = 0.066 (0.02), <italic>p</italic> = 0.001, a finding specific to large-vessel and cardioembolic stroke (<italic>p</italic> = 0.001 and <italic>p</italic> = < 0.001, respectively) but not seen with small-vessel stroke (<italic>p</italic> = 0.811).</p></sec><sec><title>Interpretation</title><p><italic>ABO</italic> gene variants are associated with large-vessel and cardioembolic stroke but not small-vessel disease. This work sheds light on the different pathogenic mechanisms underpinning stroke subtype. Ann Neurol 2013</p></sec></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Lopez, Ad" uniqKey="Lopez A">AD Lopez</name></author><author><name sortKey="Mathers, Cd" uniqKey="Mathers C">CD Mathers</name></author><author><name sortKey="Ezzati, M" uniqKey="Ezzati M">M Ezzati</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Souto, Jc" uniqKey="Souto J">JC Souto</name></author><author><name sortKey="Almasy, L" uniqKey="Almasy L">L Almasy</name></author><author><name sortKey="Borrell, M" uniqKey="Borrell M">M Borrell</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Carter, Am" uniqKey="Carter A">AM Carter</name></author><author><name sortKey="Cymbalista, Cm" uniqKey="Cymbalista C">CM Cymbalista</name></author><author><name sortKey="Spector, Td" uniqKey="Spector T">TD Spector</name></author><author><name sortKey="Grant, Pj" uniqKey="Grant P">PJ Grant</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Williams, Fm" uniqKey="Williams F">FM Williams</name></author><author><name sortKey="Carter, Am" uniqKey="Carter A">AM Carter</name></author><author><name sortKey="Kato, B" uniqKey="Kato B">B Kato</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Samani, Nj" uniqKey="Samani N">NJ Samani</name></author><author><name sortKey="Erdmann, J" uniqKey="Erdmann J">J Erdmann</name></author><author><name sortKey="Hall, As" uniqKey="Hall A">AS Hall</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Manolio, Ta" uniqKey="Manolio T">TA Manolio</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Spector, Td" uniqKey="Spector T">TD Spector</name></author><author><name sortKey="Williams, Fm" uniqKey="Williams F">FM Williams</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Andrew, T" uniqKey="Andrew T">T Andrew</name></author><author><name sortKey="Hart, Dj" uniqKey="Hart D">DJ Hart</name></author><author><name sortKey="Snieder, H" uniqKey="Snieder H">H Snieder</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Carter, Am" uniqKey="Carter A">AM Carter</name></author><author><name sortKey="Catto, Aj" uniqKey="Catto A">AJ Catto</name></author><author><name sortKey="Mansfield, Mw" uniqKey="Mansfield M">MW Mansfield</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="De Lange, M" uniqKey="De Lange M">M de Lange</name></author><author><name sortKey="Snieder, H" uniqKey="Snieder H">H Snieder</name></author><author><name sortKey="Ariens, Ra" uniqKey="Ariens R">RA Ariens</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Freeman, Ms" uniqKey="Freeman M">MS Freeman</name></author><author><name sortKey="Mansfield, Mw" uniqKey="Mansfield M">MW Mansfield</name></author><author><name sortKey="Barrett, Jh" uniqKey="Barrett J">JH Barrett</name></author><author><name sortKey="Grant, Pj" uniqKey="Grant P">PJ Grant</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Freeman, Ms" uniqKey="Freeman M">MS Freeman</name></author><author><name sortKey="Mansfield, Mw" uniqKey="Mansfield M">MW Mansfield</name></author><author><name sortKey="Barrett, Jh" uniqKey="Barrett J">JH Barrett</name></author><author><name sortKey="Grant, Pj" uniqKey="Grant P">PJ Grant</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Evans, A" uniqKey="Evans A">A Evans</name></author><author><name sortKey="Salomaa, V" uniqKey="Salomaa V">V Salomaa</name></author><author><name sortKey="Kulathinal, S" uniqKey="Kulathinal S">S Kulathinal</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kulathinal, S" uniqKey="Kulathinal S">S Kulathinal</name></author><author><name sortKey="Karvanen, J" uniqKey="Karvanen J">J Karvanen</name></author><author><name sortKey="Saarela, O" uniqKey="Saarela O">O Saarela</name></author><author><name sortKey="Kuulasmaa, K" uniqKey="Kuulasmaa K">K Kuulasmaa</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Adams, Hp" uniqKey="Adams H">HP Adams</name></author><author><name sortKey="Bendixen, Bh" uniqKey="Bendixen B">BH Bendixen</name></author><author><name sortKey="Kappelle, Lj" uniqKey="Kappelle L">LJ Kappelle</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bellenguez, C" uniqKey="Bellenguez C">C Bellenguez</name></author><author><name sortKey="Bevan, S" uniqKey="Bevan S">S Bevan</name></author><author><name sortKey="Gschwendtner, A" uniqKey="Gschwendtner A">A Gschwendtner</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Hysi, Pg" uniqKey="Hysi P">PG Hysi</name></author><author><name sortKey="Young, Tl" uniqKey="Young T">TL Young</name></author><author><name sortKey="Mackey, Da" uniqKey="Mackey D">DA Mackey</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Marchini, J" uniqKey="Marchini J">J Marchini</name></author><author><name sortKey="Howie, B" uniqKey="Howie B">B Howie</name></author><author><name sortKey="Myers, S" uniqKey="Myers S">S Myers</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Silander, K" uniqKey="Silander K">K Silander</name></author><author><name sortKey="Alanne, M" uniqKey="Alanne M">M Alanne</name></author><author><name sortKey="Kristiansson, K" uniqKey="Kristiansson K">K Kristiansson</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Purcell, S" uniqKey="Purcell S">S Purcell</name></author><author><name sortKey="Neale, B" uniqKey="Neale B">B Neale</name></author><author><name sortKey="Todd Brown, K" uniqKey="Todd Brown K">K Todd-Brown</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Willer, Cj" uniqKey="Willer C">CJ Willer</name></author><author><name sortKey="Li, Y" uniqKey="Li Y">Y Li</name></author><author><name sortKey="Abecasis, Gr" uniqKey="Abecasis G">GR Abecasis</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Abecasis, Gr" uniqKey="Abecasis G">GR Abecasis</name></author><author><name sortKey="Cherny, Ss" uniqKey="Cherny S">SS Cherny</name></author><author><name sortKey="Cookson, Wo" uniqKey="Cookson W">WO Cookson</name></author><author><name sortKey="Cardon, Lr" uniqKey="Cardon L">LR Cardon</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Smith, Nl" uniqKey="Smith N">NL Smith</name></author><author><name sortKey="Chen, Mh" uniqKey="Chen M">MH Chen</name></author><author><name sortKey="Dehghan, A" uniqKey="Dehghan A">A Dehghan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ionescu, Da" uniqKey="Ionescu D">DA Ionescu</name></author><author><name sortKey="Marcu, I" uniqKey="Marcu I">I Marcu</name></author><author><name sortKey="Bicescu, E" uniqKey="Bicescu E">E Bicescu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wu, O" uniqKey="Wu O">O Wu</name></author><author><name sortKey="Bayoumi, N" uniqKey="Bayoumi N">N Bayoumi</name></author><author><name sortKey="Vickers, Ma" uniqKey="Vickers M">MA Vickers</name></author><author><name sortKey="Clark, P" uniqKey="Clark P">P Clark</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Reilly, Mp" uniqKey="Reilly M">MP Reilly</name></author><author><name sortKey="Li, M" uniqKey="Li M">M Li</name></author><author><name sortKey="He, J" uniqKey="He J">J He</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Schunkert, H" uniqKey="Schunkert H">H Schunkert</name></author><author><name sortKey="Konig, Ir" uniqKey="Konig I">IR Konig</name></author><author><name sortKey="Kathiresan, S" uniqKey="Kathiresan S">S Kathiresan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wiggins, Kl" uniqKey="Wiggins K">KL Wiggins</name></author><author><name sortKey="Smith, Nl" uniqKey="Smith N">NL Smith</name></author><author><name sortKey="Glazer, Nl" uniqKey="Glazer N">NL Glazer</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wolpin, Bm" uniqKey="Wolpin B">BM Wolpin</name></author><author><name sortKey="Kabrhel, C" uniqKey="Kabrhel C">C Kabrhel</name></author><author><name sortKey="Varraso, R" uniqKey="Varraso R">R Varraso</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tregouet, Da" uniqKey="Tregouet D">DA Tregouet</name></author><author><name sortKey="Heath, S" uniqKey="Heath S">S Heath</name></author><author><name sortKey="Saut, N" uniqKey="Saut N">N Saut</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Suhre, K" uniqKey="Suhre K">K Suhre</name></author><author><name sortKey="Shin, Sy" uniqKey="Shin S">SY Shin</name></author><author><name sortKey="Petersen, Ak" uniqKey="Petersen A">AK Petersen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="King, A" uniqKey="King A">A King</name></author><author><name sortKey="Markus, Hs" uniqKey="Markus H">HS Markus</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Markus, Hs" uniqKey="Markus H">HS Markus</name></author><author><name sortKey="Mccollum, C" uniqKey="Mccollum C">C McCollum</name></author><author><name sortKey="Imray, C" uniqKey="Imray C">C Imray</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Pantoni, L" uniqKey="Pantoni L">L Pantoni</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gretarsdottir, S" uniqKey="Gretarsdottir S">S Gretarsdottir</name></author><author><name sortKey="Thorleifsson, G" uniqKey="Thorleifsson G">G Thorleifsson</name></author><author><name sortKey="Manolescu, A" uniqKey="Manolescu A">A Manolescu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gudbjartsson, Df" uniqKey="Gudbjartsson D">DF Gudbjartsson</name></author><author><name sortKey="Holm, H" uniqKey="Holm H">H Holm</name></author><author><name sortKey="Gretarsdottir, S" uniqKey="Gretarsdottir S">S Gretarsdottir</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gschwendtner, A" uniqKey="Gschwendtner A">A Gschwendtner</name></author><author><name sortKey="Bevan, S" uniqKey="Bevan S">S Bevan</name></author><author><name sortKey="Cole, Jw" uniqKey="Cole J">JW Cole</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kubo, M" uniqKey="Kubo M">M Kubo</name></author><author><name sortKey="Hata, J" uniqKey="Hata J">J Hata</name></author><author><name sortKey="Ninomiya, T" uniqKey="Ninomiya T">T Ninomiya</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Bernardi, F" uniqKey="Bernardi F">F Bernardi</name></author><author><name sortKey="Arcieri, P" uniqKey="Arcieri P">P Arcieri</name></author><author><name sortKey="Bertina, Rm" uniqKey="Bertina R">RM Bertina</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Calafell, F" uniqKey="Calafell F">F Calafell</name></author><author><name sortKey="Almasy, L" uniqKey="Almasy L">L Almasy</name></author><author><name sortKey="Sabater Lleal, M" uniqKey="Sabater Lleal M">M Sabater-Lleal</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Nothnagel, M" uniqKey="Nothnagel M">M Nothnagel</name></author><author><name sortKey="Ellinghaus, D" uniqKey="Ellinghaus D">D Ellinghaus</name></author><author><name sortKey="Schreiber, S" uniqKey="Schreiber S">S Schreiber</name></author></analytic></biblStruct></listBibl></div1></back></TEI><pmc article-type="research-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Neurol</journal-id><journal-id journal-id-type="iso-abbrev">Ann. Neurol</journal-id><journal-id journal-id-type="publisher-id">ana</journal-id><journal-title-group><journal-title>Annals of Neurology</journal-title></journal-title-group><issn pub-type="ppub">0364-5134</issn><issn pub-type="epub">1531-8249</issn><publisher><publisher-name>Wiley Subscription Services, Inc., A Wiley Company</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23381943</article-id><article-id pub-id-type="pmc">3582024</article-id><article-id pub-id-type="doi">10.1002/ana.23838</article-id><article-categories><subj-group subj-group-type="heading"><subject>Rapid Communication</subject></subj-group></article-categories><title-group><article-title>Ischemic Stroke Is Associated with the <italic>ABO</italic> Locus: The EuroCLOT Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Williams</surname><given-names>Frances M K</given-names></name><degrees>PhD, FRCP(E)</degrees><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name><surname>Carter</surname><given-names>Angela M</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="au2">2</xref></contrib><contrib contrib-type="author"><name><surname>Hysi</surname><given-names>Pirro G</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name><surname>Surdulescu</surname><given-names>Gabriela</given-names></name><degrees>MSc</degrees><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hodgkiss</surname><given-names>Dylan</given-names></name><degrees>MSc</degrees><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name><surname>Soranzo</surname><given-names>Nicole</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="au3">3</xref><xref ref-type="aff" rid="au4">4</xref><xref ref-type="aff" rid="au5">5</xref></contrib><contrib contrib-type="author"><name><surname>Traylor</surname><given-names>Matthew</given-names></name><degrees>MSc</degrees><xref ref-type="aff" rid="au6">6</xref></contrib><contrib contrib-type="author"><name><surname>Bevan</surname><given-names>Steve</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="au6">6</xref></contrib><contrib contrib-type="author"><name><surname>Dichgans</surname><given-names>Martin</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="au7">7</xref></contrib><contrib contrib-type="author"><name><surname>Rothwell</surname><given-names>Peter M W</given-names></name><degrees>MD, PhD, FMedSci</degrees><xref ref-type="aff" rid="au8">8</xref></contrib><contrib contrib-type="author"><name><surname>Sudlow</surname><given-names>Cathie</given-names></name><degrees>DPhil, FRCP(E)</degrees><xref ref-type="aff" rid="au9">9</xref></contrib><contrib contrib-type="author"><name><surname>Farrall</surname><given-names>Martin</given-names></name><degrees>PhD, FRCPath</degrees><xref ref-type="aff" rid="au10">10</xref></contrib><contrib contrib-type="author"><name><surname>Silander</surname><given-names>Kaisa</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="au11">11</xref></contrib><contrib contrib-type="author"><name><surname>Kaunisto</surname><given-names>Mari</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="au11">11</xref></contrib><contrib contrib-type="author"><name><surname>Wagner</surname><given-names>Peter</given-names></name><degrees>BSc</degrees><xref ref-type="aff" rid="au11">11</xref></contrib><contrib contrib-type="author"><name><surname>Saarela</surname><given-names>Olli</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="au12">12</xref></contrib><contrib contrib-type="author"><name><surname>Kuulasmaa</surname><given-names>Kari</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="au12">12</xref></contrib><contrib contrib-type="author"><name><surname>Virtamo</surname><given-names>Jarmo</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="au12">12</xref></contrib><contrib contrib-type="author"><name><surname>Salomaa</surname><given-names>Veikko</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="au12">12</xref></contrib><contrib contrib-type="author"><name><surname>Amouyel</surname><given-names>Philippe</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="au13">13</xref></contrib><contrib contrib-type="author"><name><surname>Arveiler</surname><given-names>Dominique</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="au14">14</xref></contrib><contrib contrib-type="author"><name><surname>Ferrieres</surname><given-names>Jean</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="au15">15</xref></contrib><contrib contrib-type="author"><name><surname>Wiklund</surname><given-names>Per-Gunnar</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="au16">16</xref></contrib><contrib contrib-type="author"><name><surname>Arfan Ikram</surname><given-names>M</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="au17">17</xref></contrib><contrib contrib-type="author"><name><surname>Hofman</surname><given-names>Albert</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="au17">17</xref></contrib><contrib contrib-type="author"><name><surname>Boncoraglio</surname><given-names>Giorgio B</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="au18">18</xref></contrib><contrib contrib-type="author"><name><surname>Parati</surname><given-names>Eugenio A</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="au18">18</xref></contrib><contrib contrib-type="author"><name><surname>Helgadottir</surname><given-names>Anna</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="au10">10</xref><xref ref-type="aff" rid="au19">19</xref></contrib><contrib contrib-type="author"><name><surname>Gretarsdottir</surname><given-names>Solveig</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="au19">19</xref></contrib><contrib contrib-type="author"><name><surname>Thorsteinsdottir</surname><given-names>Unnur</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="au19">19</xref></contrib><contrib contrib-type="author"><name><surname>Thorleifsson</surname><given-names>Gudmar</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="au19">19</xref></contrib><contrib contrib-type="author"><name><surname>Stefansson</surname><given-names>Kari</given-names></name><degrees>PhD, Dr med</degrees><xref ref-type="aff" rid="au19">19</xref></contrib><contrib contrib-type="author"><name><surname>Seshadri</surname><given-names>Sudha</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="au20">20</xref><xref ref-type="aff" rid="au21">21</xref><xref ref-type="aff" rid="au22">22</xref></contrib><contrib contrib-type="author"><name><surname>DeStefano</surname><given-names>Anita</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="au20">20</xref><xref ref-type="aff" rid="au21">21</xref><xref ref-type="aff" rid="au22">22</xref></contrib><contrib contrib-type="author"><name><surname>Gschwendtner</surname><given-names>Andreas</given-names></name><degrees>Dr med</degrees><xref ref-type="aff" rid="au7">7</xref></contrib><contrib contrib-type="author"><name><surname>Psaty</surname><given-names>Bruce</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="au23">23</xref><xref ref-type="aff" rid="au24">24</xref><xref ref-type="aff" rid="au25">25</xref><xref ref-type="aff" rid="au26">26</xref></contrib><contrib contrib-type="author"><name><surname>Longstreth</surname><given-names>Will</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="au23">23</xref><xref ref-type="aff" rid="au24">24</xref><xref ref-type="aff" rid="au27">27</xref></contrib><contrib contrib-type="author"><name><surname>Mitchell</surname><given-names>Braxton D</given-names></name><degrees>MPH, PhD</degrees><xref ref-type="aff" rid="au28">28</xref></contrib><contrib contrib-type="author"><name><surname>Cheng</surname><given-names>Yu-Ching</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="au28">28</xref></contrib><contrib contrib-type="author"><name><surname>Clarke</surname><given-names>Robert</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="au29">29</xref></contrib><contrib contrib-type="author"><name><surname>Ferrario</surname><given-names>Marco</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="au30">30</xref></contrib><contrib contrib-type="author"><name><surname>Bis</surname><given-names>Joshua C</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="au31">31</xref></contrib><contrib contrib-type="author"><name><surname>Levi</surname><given-names>Christopher</given-names></name><degrees>BSc, MBBS</degrees><xref ref-type="aff" rid="au32">32</xref><xref ref-type="aff" rid="au33">33</xref><xref ref-type="aff" rid="au34">34</xref></contrib><contrib contrib-type="author"><name><surname>Attia</surname><given-names>John</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="au32">32</xref><xref ref-type="aff" rid="au33">33</xref><xref ref-type="aff" rid="au34">34</xref></contrib><contrib contrib-type="author"><name><surname>Holliday</surname><given-names>Elizabeth G</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="au32">32</xref><xref ref-type="aff" rid="au33">33</xref><xref ref-type="aff" rid="au34">34</xref></contrib><contrib contrib-type="author"><name><surname>Scott</surname><given-names>Rodney J</given-names></name><degrees>PhD, FRCPath</degrees><xref ref-type="aff" rid="au32">32</xref><xref ref-type="aff" rid="au33">33</xref><xref ref-type="aff" rid="au34">34</xref></contrib><contrib contrib-type="author"><name><surname>Fornage</surname><given-names>Myriam</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="au35">35</xref></contrib><contrib contrib-type="author"><name><surname>Sharma</surname><given-names>Pankaj</given-names></name><degrees>PhD, FRCP</degrees><xref ref-type="aff" rid="au36">36</xref></contrib><contrib contrib-type="author"><name><surname>Furie</surname><given-names>Karen L</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="au37">37</xref></contrib><contrib contrib-type="author"><name><surname>Rosand</surname><given-names>Jonathan</given-names></name><degrees>MD, MSc</degrees><xref ref-type="aff" rid="au37">37</xref></contrib><contrib contrib-type="author"><name><surname>Nalls</surname><given-names>Mike</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="au38">38</xref></contrib><contrib contrib-type="author"><name><surname>Meschia</surname><given-names>James</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="au38">38</xref></contrib><contrib contrib-type="author"><name><surname>Mosely</surname><given-names>Thomas H</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="au39">39</xref></contrib><contrib contrib-type="author"><name><surname>Evans</surname><given-names>Alun</given-names></name><degrees>MD</degrees></contrib><contrib contrib-type="author"><name><surname>Palotie</surname><given-names>Aarno</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="au3">3</xref><xref ref-type="aff" rid="au4">4</xref><xref ref-type="aff" rid="au5">5</xref><xref ref-type="aff" rid="au11">11</xref></contrib><contrib contrib-type="author"><name><surname>Markus</surname><given-names>Hugh S</given-names></name><degrees>MD, FRCP</degrees><xref ref-type="aff" rid="au6">6</xref></contrib><contrib contrib-type="author"><name><surname>Grant</surname><given-names>Peter J</given-names></name><degrees>MD, FRCP</degrees><xref ref-type="aff" rid="au2">2</xref></contrib><contrib contrib-type="author"><name><surname>Spector</surname><given-names>Tim D</given-names></name><degrees>MD, FRCP</degrees><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><collab>on Behalf of the EuroCLOT Investigators, the Wellcome Trust Case Control Consortium 2, MOnica Risk, Genetics, Archiving and Monograph, MetaStroke, and the International Stroke Genetics Consortium</collab></contrib><aff id="au1"><label>1</label><institution>Department of Twin Research and Genetic Epidemiology, King's College London</institution><addr-line>London, United Kingdom</addr-line></aff><aff id="au2"><label>2</label><institution>Division of Cardiovascular and Diabetes Research, University of Leeds</institution><addr-line>Leeds, United Kingdom</addr-line></aff><aff id="au3"><label>3</label><institution>Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus</institution><addr-line>Hinxton, United Kingdom</addr-line></aff><aff id="au4"><label>4</label><institution>Program in Medical and Population Genetics and Genetic Analysis Platform, Broad Institute of Massachusetts Institute of Technology and Harvard</institution><addr-line>Cambridge, MA</addr-line></aff><aff id="au5"><label>5</label><institution>Department of Medical Genetics, University of Helsinki and University Central Hospital</institution><addr-line>Helsinki, Finland</addr-line></aff><aff id="au6"><label>6</label><institution>Stroke and Dementia Research Centre, St George's University of London</institution><addr-line>London, United Kingdom</addr-line></aff><aff id="au7"><label>7</label><institution>Institute for Stroke and Dementia Research, Klinikum der Universität Munich, Ludwig-Maximilians-University</institution><addr-line>Munich, Germany</addr-line></aff><aff id="au8"><label>8</label><institution>Stroke Prevention Research Unit, University Department of Clinical Neurology, Oxford University</institution><addr-line>Oxford, United Kingdom</addr-line></aff><aff id="au9"><label>9</label><institution>Division of Clinical Neurosciences, University of Edinburgh</institution><addr-line>Edinburgh, United Kingdom</addr-line></aff><aff id="au10"><label>10</label><institution>Wellcome Trust Centre for Human Genetics and Department of Cardiovascular Medicine, University of Oxford</institution><addr-line>Oxford, United Kingdom</addr-line></aff><aff id="au11"><label>11</label><institution>Institute for Molecular Medicine Finland, University of Helsinki</institution><addr-line>Helsinki, Finland</addr-line></aff><aff id="au12"><label>12</label><institution>Chronic Disease Epidemiology and Prevention Unit, National Institute for Health and Welfare</institution><addr-line>Helsinki, Finland</addr-line></aff><aff id="au13"><label>13</label><institution>Department of Epidemiology and Public Health, Pasteur Institute of Lille</institution><addr-line>Lille, France</addr-line></aff><aff id="au14"><label>14</label><institution>Department of Epidemiology and Public Health, University of Strasbourg</institution><addr-line>Strasbourg, France</addr-line></aff><aff id="au15"><label>15</label><institution>Department of Epidemiology, Faculty of Medicine</institution><addr-line>Toulouse-Purpan, Toulouse, France</addr-line></aff><aff id="au16"><label>16</label><institution>Department of Internal Medicine, University of Umeå</institution><addr-line>Umeå, Sweden</addr-line></aff><aff id="au17"><label>17</label><institution>Department of Epidemiology, Erasmus University Medical Center</institution><addr-line>Rotterdam, the Netherlands</addr-line></aff><aff id="au18"><label>18</label><institution>Department of Neurology, Research Hospital of the Neurological Institute “Carlo Besta,”</institution><addr-line>Milan, Italy</addr-line></aff><aff id="au19"><label>19</label><institution>DeCODE Genetics</institution><addr-line>Reykjavik, Iceland</addr-line></aff><aff id="au20"><label>20</label><institution>Boston University Schools of Medicine and Public Health</institution><addr-line>Boston, MA</addr-line></aff><aff id="au21"><label>21</label><institution>Framingham Heart Study</institution><addr-line>Framingham, MA</addr-line></aff><aff id="au22"><label>22</label><institution>Departments of Health Services, University of Washington</institution><addr-line>Seattlem WA</addr-line></aff><aff id="au23"><label>23</label><institution>Epidemiology, Health Services, University of Washington</institution><addr-line>Seattle, WA</addr-line></aff><aff id="au24"><label>24</label><institution>Medicine, and Health Services, University of Washington</institution><addr-line>Seattle, WA</addr-line></aff><aff id="au25"><label>25</label><institution>Group Health Research Institute, Group Health</institution><addr-line>Seattle, WA</addr-line></aff><aff id="au26"><label>26</label><institution>Department of Neurology, University of Washington</institution><addr-line>WA</addr-line></aff><aff id="au27"><label>27</label><institution>Department of Medicine, University of Maryland</institution><addr-line>Baltimore, MD</addr-line></aff><aff id="au28"><label>28</label><institution>Clinical Trial Service Unit, University of Oxford</institution><addr-line>Oxford, United Kingdom</addr-line></aff><aff id="au29"><label>29</label><institution>University of Insubria</institution><addr-line>Varese, Italy</addr-line></aff><aff id="au30"><label>30</label><institution>Cardiovascular Health Research Unit, Department of Medicine, University of Washington</institution><addr-line>Seattle, WA</addr-line></aff><aff id="au31"><label>31</label><institution>University of Newcastle</institution><addr-line>Callaghan, Australia</addr-line></aff><aff id="au32"><label>32</label><institution>John Hunter Hospital</institution><addr-line>New Lambton Heights, Australia</addr-line></aff><aff id="au33"><label>33</label><institution>Hunter Medical Research Institute</institution><addr-line>New Lambton, Australia</addr-line></aff><aff id="au34"><label>34</label><institution>Human Genetics Center and Institute of Molecular Medicine, University of Texas Health Sciences Center</institution><addr-line>Houston, TX</addr-line></aff><aff id="au35"><label>35</label><institution>Imperial College Cerebrovascular Research Unit, Imperial College London</institution><addr-line>London, United Kingdom</addr-line></aff><aff id="au36"><label>36</label><institution>Center for Human Genetic Research, Massachusetts General Hospital and Harvard Medical School</institution><addr-line>Boston, MA</addr-line></aff><aff id="au37"><label>37</label><institution>Department of Neurology, Mayo Clinic</institution><addr-line>Jacksonville, FL, USA</addr-line></aff><aff id="au38"><label>38</label><institution>University of Mississippi Medical Center</institution><addr-line>Jackson, MS</addr-line></aff><aff id="au39"><label>39</label><institution>Queen's University of Belfast</institution><addr-line>Belfast, United Kingdom</addr-line></aff></contrib-group><author-notes><corresp id="cor1">Address correspondence to Dr Williams, Department of Twin Research and Genetic Epidemiology, King's College London, St Thomas' Hospital Campus, 3rd Floor South Wing Block 8, Westminster Bridge Road, London, SE1 7EH. E-mail: <email>frances.williams@kcl.ac.uk</email></corresp><fn><p>Wellcome Trust Case Control Consortium 2 members are listed in the Appendix on page 29.</p></fn></author-notes><pub-date pub-type="ppub"><month>1</month><year>2013</year></pub-date><pub-date pub-type="epub"><day>04</day><month>2</month><year>2013</year></pub-date><volume>73</volume><issue>1</issue><fpage>16</fpage><lpage>31</lpage><history><date date-type="received"><day>27</day><month>4</month><year>2012</year></date><date date-type="rev-recd"><day>21</day><month>9</month><year>2012</year></date><date date-type="accepted"><day>29</day><month>10</month><year>2012</year></date></history><permissions><copyright-statement>Copyright © 2012 American Neurological Association</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/"><license-p>Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.</license-p></license></permissions><abstract><sec><title>Objective</title><p>End-stage coagulation and the structure/function of fibrin are implicated in the pathogenesis of ischemic stroke. We explored whether genetic variants associated with end-stage coagulation in healthy REFVIDunteers account for the genetic predisposition to ischemic stroke and examined their influence on stroke subtype.</p></sec><sec><title>Methods</title><p>Common genetic variants identified through genome-wide association studies of coagulation factors and fibrin structure/function in healthy twins (n = 2,100, Stage 1) were examined in ischemic stroke (n = 4,200 cases) using 2 independent samples of European ancestry (Stage 2). A third clinical collection having stroke subtyping (total 8,900 cases, 55,000 controls) was used for replication (Stage 3).</p></sec><sec><title>Results</title><p>Stage 1 identified 524 single nucleotide polymorphisms (SNPs) from 23 linkage disequilibrium blocks having significant association (<italic>p</italic> < 5 × 10<sup>–8</sup>) with 1 or more coagulation/fibrin phenotypes. The most striking associations included SNP rs5985 with factor XIII activity (<italic>p</italic> = 2.6 × 10<sup>–186</sup>), rs10665 with FVII (<italic>p</italic> = 2.4 × 10<sup>–47</sup>), and rs505922 in the <italic>ABO</italic> gene with both von Willebrand factor (<italic>p</italic> = 4.7 × 10<sup>–57</sup>) and factor VIII (<italic>p</italic> = 1.2 × 10<sup>–36</sup>). In Stage 2, the 23 independent SNPs were examined in stroke cases/noncases using MOnica Risk, Genetics, Archiving and Monograph (MORGAM) and Wellcome Trust Case Control Consortium 2 collections. SNP rs505922 was nominally associated with ischemic stroke (odds ratio = 0.94, 95% confidence interval = 0.88–0.99, <italic>p</italic> = 0.023). Independent replication in Meta-Stroke confirmed the rs505922 association with stroke, beta (standard error, SE) = 0.066 (0.02), <italic>p</italic> = 0.001, a finding specific to large-vessel and cardioembolic stroke (<italic>p</italic> = 0.001 and <italic>p</italic> = < 0.001, respectively) but not seen with small-vessel stroke (<italic>p</italic> = 0.811).</p></sec><sec><title>Interpretation</title><p><italic>ABO</italic> gene variants are associated with large-vessel and cardioembolic stroke but not small-vessel disease. This work sheds light on the different pathogenic mechanisms underpinning stroke subtype. Ann Neurol 2013</p></sec></abstract></article-meta></front><body><p>Ischemic stroke is among the leading causes of death and disability in high-income countries.<xref ref-type="bibr" rid="b1">1</xref> EuroCLOT is a European Union–funded multicenter study established to identify the genetic variants contributing to end-stage coagulation, as a means of exploring whether the same variants contribute to risk of ischemic stroke. It is known that genetic factors account for approximately 60% of the risk of thrombosis,<xref ref-type="bibr" rid="b2">2</xref> and studies have demonstrated the influence of genetic factors on the individual components of coagulation and fibrinolysis. Furthermore, ex vivo measures of fibrin structure and fibrinolysis have been shown to be heritable.<xref ref-type="bibr" rid="b3">3</xref> The nature of the structure and function of fibrin has been shown to influence clot behavior, and earlier work by the EuroCLOT consortium has demonstrated heritability of fibrin clot phenotypes measured by a high-throughput turbidimetric assay and several regions of linkage.<xref ref-type="bibr" rid="b4">4</xref> The goal of this study was to extend these observations by using the genome-wide association (GWA) approach to identify common genetic loci associated with coagulation phenotypes and to determine whether associated loci were further associated with the clinically important phenotype ischemic stroke and its different subtypes. GWA studies have identified common genetic loci of small effect associated with clinical phenotypes such as coronary artery disease.<xref ref-type="bibr" rid="b5">5</xref> The GWA method allows an agnostic study of variation within the genome, unbiased by prior knowledge of the cellular pathways inREFVIDved or the use of candidate genes, and has been successful in finding hundreds of gene loci to date.<xref ref-type="bibr" rid="b6">6</xref> The overall aim was to determine whether genetic variants associated with coagulation and fibrin structure function were risk factors for ischemic stroke and if so whether such associations differed between stroke subtypes.</p><sec sec-type="methods"><title>Subjects and Methods</title><p>We used a 3-stage study design to identify common variants influencing coagulation and fibrin structure/function in the normal population and then tested genome-wide significant independent single nucleotide polymorphisms (SNPs) for association with stroke in subjects of Northern European extraction (<xref ref-type="fig" rid="fig01">Fig 1</xref>). To study the broad range of hemostatic variables contributing to end-stage coagulation, GWA studies of fibrin structure/function ex vivo, fibrin turnover (D-dimer) in vivo, and individual hemostatic components were performed in a healthy REFVIDunteer cohort of twins (Stage 1). In Stage 2, those variants found to be independently associated with coagulation or fibrin structure/function were assessed as risk factors for ischemic stroke in cases and controls. In Stage 3, the top 4 SNPs from the meta-analysis of ischemic stroke were examined for replication in a third clinical collection of stroke having information on whether stroke resulted from occlusion of large-vessel, small-vessel, or cardiac emboli. Detailed methods are provided below. Written informed consent was obtained from participants in the study, and each individual study group obtained local ethics approval.</p><fig id="fig01" position="float"><label>FIGURE 1</label><caption><p>Flow chart showing study design and cohorts involved. The 3 stages of the study design are shown, with number of cases in each sample. GWA = genome-wide association; n = size of the cohort; SNP = single nucleotide polymorphism; TUK = TwinsUK; WTCCC2 = Wellcome Trust Case Control Consortium 2.</p></caption><graphic xlink:href="ana0073-0016-f1"></graphic></fig></sec><sec><title>Phenotyping the Cohorts</title><p>TwinsUK. The subjects were obtained from the TwinsUK (TUK) registry (<ext-link ext-link-type="uri" xlink:href="http://www.twinsuk.ac.uk">http://www.twinsuk.ac.uk</ext-link>) at King's College London, United Kingdom, which has been ascertained by a national media campaign.<xref ref-type="bibr" rid="b7">7</xref> For historical reasons, the majority of twin REFVIDunteers are female. TUK subjects have been shown to be representative of the wider general populations for genetic and lifestyle factors associated with a variety of traits.<xref ref-type="bibr" rid="b8">8</xref> TUK subjects were phenotyped for fibrin structure/function, D-dimer, and hemostatic factors, according to methods described in detail elsewhere.<xref ref-type="bibr" rid="b9">9</xref>–<xref ref-type="bibr" rid="b12">12</xref> In brief, fibrin structure/function was assessed using a turbidimetric assay, whereas D-dimer (as a measure of in vivo fibrin turnover), coagulation factors (F) VII, VIII, FXII, FXIII A and B subunits (FXIIIA, FXIIIIB), prothrombin, and von Willebrand Factor (vWF) were quantified by enzyme-linked immunosorbent assay, and fibrinogen, FVII, and FXIII by functional activity assays.</p><p>The MOnica Risk, Genetics, Archiving and Monograph (MORGAM) Cohort. The cohorts of the MORGAM project consist of the respondents of representative adult population samples.<xref ref-type="bibr" rid="b13">13</xref> This study includes cohorts from a variety of centers, including Finland (FINRISK, ATBC), France (Lille, Strasbourg, Toulouse), Italy (Brianza), Northern Sweden, and Northern Ireland (Belfast) as described at <ext-link ext-link-type="uri" xlink:href="http://www.ktl.fi/publications/morgam/cohorts">http://www.ktl.fi/publications/morgam/cohorts</ext-link>. The participants were examined and DNA was collected at baseline, and they were followed up for stroke and acute coronary events. Genotyping was carried out in a case–cohort setting.<xref ref-type="bibr" rid="b14">14</xref> In MORGAM cohorts, the end-point used was the subject presenting with first ischemic stroke. For some events the diagnosis was based on validation, and for some on the clinical or death certificate diagnosis (International Classification of Diseases [ICD]-9 codes 433 or 434, or ICD-10 code I63).</p><p>Wellcome Trust Case Control Consortium 2. The Wellcome Trust Case Control Consortium 2 (WTCCC2) ischemic stroke study comprises ischemic stroke cases recruited from 3 centers in the United Kingdom (St George's London, Oxford, and Edinburgh) and 1 center in Munich, Germany. In all cases, ischemic stroke was defined as a focal neurological deficit lasting >24 hours; in 1 cohort (St George's), cases of transient ischemic attack with associated recent brain infraction were also included. Cerebral infraction was confirmed on brain imaging with computed tomography (CT) or magnetic resonance (MR) imaging, which was performed in 100% of cases, and extensive phenotyping was performed to allow stroke subtyping using a modified TOAST classification.<xref ref-type="bibr" rid="b15">15</xref> Full details of populations and investigation performed have been previously published.<xref ref-type="bibr" rid="b16">16</xref> Imaging of the cerebral arteries using carotid and vertebral duplex ultrasound and/or MR angiography or CT angiography was performed in >95%, echocardiography in 59.7%. Controls for the UK cases were the shared WTCCC2 controls drawn from the National Blood Service or the 1958 Birth Cohort Study (<ext-link ext-link-type="uri" xlink:href="http://www.b58cgene.sgul.ac.uk">http://www.b58cgene.sgul.ac.uk</ext-link>). German controls werefrom the population-based KORAgen study <ext-link ext-link-type="uri" xlink:href="(http://www.helmholtz-muenchen.de/en/kora-en/kora-homepage/index.html)">(http://www.helmholtz-muenchen.de/en/kora-en/kora-homepage/index.html)</ext-link>. This study group was used primarily in Stage 2 but also for subgroup analysis in Stage 3.</p><p>MetaStroke. MetaStroke is a project of the International Stroke Genetics Consortium and comprises ischemic stroke cases whose DNA has been collected and undergone GWA scan, recruited from centers in Europe (BRAINS [Bio-Repository of DNA in Stroke], United Kingdom; DeCODE, Iceland; Cerebrovascular Diseases Registry (CEDIR), Milan, Italy; Rotterdam, the Netherlands), USA (Atherosclerosis Risk in Communities study; Cardiovascular Health Study; Framingham Heart Study; Genetics of Early Onset Stroke Study; Heart Protection Study; Heart and Vascular Health; Ischemic Stroke Genetics Study; Massachusetts General Hospital Genes Affecting Stroke Risk and Outcome study), and Australia (Australian Stroke Genetics Collaborative). Ischemic stroke was defined clinically as a focal neurological deficit lasting >24 hours. In almost all case–control studies, a high level of brain imaging and extensive phenotyping was performed, although this was less detailed in some of the prospective studies. In those studies with adequate investigations to allow stroke subtyping, this was performed using a modified TOAST classification.<xref ref-type="bibr" rid="b15">15</xref> Controls were collected by the individual groups.</p></sec><sec><title>Genotyping and Within-Cohort Analysis</title><p>TUK. Genotyping was performed in 3 different genotypic batches using Human Hap 300 k Duo and Human Hap610 Quad array (Illumina, San Diego, CA). Genotyping results from the different arrays were collated and quality control was performed as described previously,<xref ref-type="bibr" rid="b17">17</xref> including retention of those SNPs with sufficiently high genotyping rates (95% or above) and Hardy–Weinberg equilibrium (<italic>p</italic> > 0.0001). Imputation of nongenotyped SNPs was performed to HapMap2 Caucasian population haplotypes using IMPUTE version 2.<xref ref-type="bibr" rid="b18">18</xref> Population substructure and admixture was excluded in TUK using Eigenvector analysis.</p><p>MORGAM. Four SNPS (rs10665, rs2022309, rs5985, and rs651007) were genotyped at the National Institute for Health and Welfare in Finland. Several sample- and plate-specific quality control measures were implemented to minimize errors, and in addition genotyping quality was assessed from 5% blind duplicate samples in each 96-well plate. For 234 samples with low DNA yield, DNA was amplified and genotyped as previously described.<xref ref-type="bibr" rid="b19">19</xref> Genotyping was performed using the MassARRAY System and iPLEX Gold chemistry (Sequenom, San Diego, CA) with standard protocol. Genotype clusters were manually reviewed using Typer 4.0 software (Sequenom), and genotype calls were corrected where necessary. Genotyping success rate was >95% for all but 1 SNP (rs2022309, 91.3%), with an average success rate of 95.7%. No discrepancies were identified among a total of 1,256 successful blind duplicate genotype pairs. Cox regression analysis adapted for the case–cohort data was used to assess the association between the genotypes and ischemic stroke in the MORGAM cohorts, assuming an additive genotypic effect. The analysis was stratified by cohort and sex.</p><p>WTCCC2. Stroke cases were genotyped using the Illumina 660Q platform. Shared WTCCC2 controls were genotyped using the Illumina 1M Duo platform. German controls were genotyped using the Illumina 550 platform. Analysis of the UK and German cohorts was performed independently using PLINK<xref ref-type="bibr" rid="b20">20</xref> after quality control checking using a genotyping call rate of 98%, Hardy–Weinberg equilibrium call rate of 1e <sup>–20</sup>, and checks for individual relatedness and population stratification. The UK and German cases were then meta-analyzed using METAL.<xref ref-type="bibr" rid="b21">21</xref> Samples were identified and removed if the genome-wide patterns of diversity differed from those of the collection at large, interpreting them as likely to be due to biases or artifacts. To do so, we used a Bayesian clustering approach to infer outlying individuals on the basis of call rate, heterozygosity, ancestry, and average probe intensity. We used a hidden Markov model to infer identity by descent along the genome and removed individuals iteratively to obtain a set with pair-wise identity by descent <5%. Samples were also removed if their inferred gender was discordant with the recorded gender or if <90% of the SNPs typed by Sequenom (Sequenom iPLEX assay for 4 gender SNPs) were concordant with the genome-wide data. For the EuroCLOT study, individual UK and German cohort and meta-analysis results were examined for the 23 available genotypes. This was performed for the phenotype of all ischemic stroke, together with the ischemic stroke subtypes of small-vessel disease, large-vessel disease, and cardioembolic stroke.</p><p>MetaStroke. Genotyping of the 13 MetaStroke contributors was performed independently by each group, using either Illumina or Affymetrix (Santa Clara, CA) platforms. Further details on cases and controls, genotyping, and imputation are available in Supplementary <xref ref-type="table" rid="tbl3">Table 3</xref>.</p></sec><sec><title>Statistical Analysis</title><p>Stage 1. We used multiple linear regression models to assess association between genotypes and phenotypes, using age as a covariate. The phenotypes examined in the TUK cohort were inverse-normal transformed to satisfy the assumption of normality of trait distribution of the linear models. Association analysis was carried out using Merlin<xref ref-type="bibr" rid="b22">22</xref> to control for family structure within the dataset. Independence of the effects conferred by SNPs in the same region was assessed by means of a backward stepwise regression analysis on the trait with which they were associated. This yielded 23 statistically independent significant SNPs (<italic>p</italic> < 5 × 10<sup>–8</sup>), associated with at least 1 quantitative outcome, which were taken forward for examination in the clinical groups at Stage 2. This stage of the analysis was performed using Stata for Windows version 10 (StataCorp, College Station, TX) with adjustment for the twins' relatedness.</p><p>Stage 2. The 23 independent SNPs remaining significant after multiple regression were carried through to investigation of association with ischemic stroke in MORGAM and WTCCC2. Results for each were meta-analyzed using a fixed effects inverse variance weighting implemented in METAL.<xref ref-type="bibr" rid="b21">21</xref></p><p>Stage 3. The 4 most significantly associated SNPs from Stage 2 were tested for association with overall ischemic stroke in Meta-Stroke. This international collaboration brings together GWA studies in ischemic stroke and (depending on SNP) includes 8,900 cases of ischemic stroke and 55,000 controls. In addition, subgroup analysis was possible (in MetaStroke and WTCCC2), as stroke events had been subphenotyped into large-vessel, small-vessel, and cardioembolic stroke by many of the contributing study groups, using the TOAST classification.<xref ref-type="bibr" rid="b15">15</xref> Within MetaStroke, samples were excluded from analysis if they had call rates <80% or if reported gender was discordant with gender-specific markers. We removed pairs of samples showing concordance indicative of being duplicates. MetaStroke genotyping results were imputed to HapMap2 using MACH2. Where SNPs were imputed, <italic>r</italic><sup>2</sup> values were >0.9. Four SNPs analyzed in these cohorts were meta-analyzed using a fixed effects model with the metan module in Stata version 10.</p></sec><sec sec-type="results"><title>Results</title><p>The characteristics of the 2,128 twin participants are shown for TUK in <xref ref-type="table" rid="tbl1">Table 1</xref> and Supplementary <xref ref-type="supplementary-material" rid="SD1">Table 1</xref> (Stage 1). The mean age of the twins was 50.4 years, and the sample included 87 (4.4%) males. All were of North European descent. The sample size varied between assays; for clarity, the number of subjects is included in the tables for each phenotype.</p><table-wrap id="tbl1" position="float"><label>TABLE 1</label><caption><p>Stage 1: Characteristics of the TwinsUK Discovery Sample</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="ana0073-0016-t1.jpg" mimetype="image"></inline-graphic></inline-formula></td></tr></tbody></table></table-wrap><p>Details of the clinical collections of stroke cases and controls are shown in <xref ref-type="table" rid="tbl2">Table 2</xref>.</p><table-wrap id="tbl2" position="float"><label>TABLE 2</label><caption><p>Stages 2 and 3: Characteristics of the Ischemic Stroke Collections</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="ana0073-0016-t2.jpg" mimetype="image"></inline-graphic></inline-formula></td></tr></tbody></table></table-wrap><sec><title>Stage 1</title><p>There were a number of strikingly strong genotype–phenotype associations identified in the TUK discovery group, and in total 524 associations were found having <italic>p</italic> < 5 × 10<sup>–8</sup>. The 524 SNPs identified as significant genome-wide were mostly associated with coagulation factor phenotypes; there was 1 association with lag time to fibrin clot formation. After the interdependence of the SNPs had been established by backward stepwise regression analysis, 23 statistically independent SNPs were identified for examination in Stage 2 (shown in <xref ref-type="table" rid="tbl3">Table 3</xref>). The strongest signals were observed for SNP rs5985 in the <italic>F13A1</italic> gene (encoding the FXIII A subunit) and FXIII activity (<italic>p</italic> = 2.6 × 10<sup>–186</sup>), followed by rs2731672 in the <italic>F12</italic> gene associated with FXII concentration (encoding FXII; <italic>p</italic> = 1.3 × 10<sup>–115</sup>; Supplementary <xref ref-type="supplementary-material" rid="SD1">Table 2</xref>) and rs505922 in the <italic>ABO</italic> gene with vWF (<italic>p</italic> = 4.7 × 10<sup>–57</sup>; see <xref ref-type="table" rid="tbl3">Table 3</xref>) and factor VIII (<italic>p</italic> = 1.2 × 10<sup>–36</sup>; see Supplementary <xref ref-type="supplementary-material" rid="SD1">Table 2</xref>). Further coagulation-related phenotype–SNP associations were identified for rs10665 in <italic>F7/MCF2L</italic> and FVII clotting activity (<italic>p</italic> = 2.4 × 10<sup>–47</sup>), and rs2022309 in the <italic>F3</italic> gene (encoding tissue factor) with D-dimer concentration (<italic>p</italic> = 4.3 × 10<sup>–8</sup>).</p><table-wrap id="tbl3" position="float"><label>TABLE 3</label><caption><p>Stage 1: Independent SNPs (n = 23) Found with p < 5 × 10<sup>-8</sup> in TwinsUK</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="ana0073-0016-t3.jpg" mimetype="image"></inline-graphic></inline-formula></td></tr></tbody></table></table-wrap><p>A clear relationship was found between plasma FXIII A subunit and SNP rs12137359 (<italic>p</italic> = 1.0 × 10<sup>–27</sup>) lying within the gene <italic>ZBTB41</italic> (zinc finger and BTB domain containing 41, a highly conserved gene). However, this region on chromosome 1q is rich with candidate genes, and the SNP in question lies downstream of the <italic>CFH</italic> and <italic>CFHR1-5</italic> genes (encoding complement factor H and CFH-related proteins 1 to 5) as well as <italic>F13B</italic> (encoding FXIII B subunit). There is also an association in this same region between rs800292 in the <italic>CFH</italic> gene and FXIIIA concentration (<italic>p</italic> = 1.5 × 10<sup>–12</sup>).</p></sec><sec><title>Stage 2</title><p>In the MORGAM study, 6 of the 23 independent SNPs were available for lookup. None of the SNPs was significantly associated with ischemic stroke in this study group or in WTCCC2, although there was a suggestion of an effect for rs505922 in both MORGAM (T allele, beta = –0.126, <italic>p</italic> = 0.067) and WTCCC2 (T allele, beta = –0.054, <italic>p</italic> = 0.097). In the meta-analysis of WTCCC2 and MORGAM, SNP rs505922 in the <italic>ABO</italic> gene was associated with ischemic stroke (beta for T allele = –0.067, <italic>p</italic> = 0.023), with the major T allele being protective against stroke (<xref ref-type="table" rid="tbl4">Table 4</xref>).</p><table-wrap id="tbl4" position="float"><label>TABLE 4</label><caption><p>Stage 2: Meta-Analysis of the Independent SNPs in Stroke</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="ana0073-0016-t4.jpg" mimetype="image"></inline-graphic></inline-formula></td></tr></tbody></table></table-wrap></sec><sec><title>Stage 3</title><p>We examined the association of the 4 <italic>ABO</italic> SNPs in the large Meta-Stroke dataset (<xref ref-type="table" rid="tbl5">Table 5</xref>, with genotyping details in Supplementary <xref ref-type="supplementary-material" rid="SD1">Table 3</xref>) and further explored their relationship with stroke subtype in Meta-Stroke and WTCCC2. Results for ischemic stroke overall are shown in <xref ref-type="table" rid="tbl6">Table 6</xref> (positive results) and are illustrated by a forest plot (<xref ref-type="fig" rid="fig02">Fig 2</xref>). The results show an association for lead SNP rs505922 C allele with ischemic stroke (odds ratio [OR] = 1.07, 95% confidence interval [CI] = 1.03–1.11, <italic>p</italic> = 0.0006). Two other <italic>ABO</italic> SNPs also showed significant association: rs643434 (for A allele, meta-analysis logistic regression OR = 1.06, 95% CI = 1.02–1.11, <italic>p</italic> = 0.002) and rs651007 (C allele, OR = 1.07, 95% CI = 1.02–1.12, <italic>p</italic> = 0.007; see <xref ref-type="table" rid="tbl6">Table 6</xref>). Analysis by stroke subtype for SNP rs505922 showed association with cardioembolic stroke (OR = 1.13, 95% CI = 1.11–1.15, <italic>p</italic> ≤ 0.001), and large-vessel stroke (OR = 1.23, 95% CI = 1.07–1.18, <italic>p</italic> = 0.001), but there was no association with small-vessel disease (<italic>p</italic> = 0.811; <xref ref-type="table" rid="tbl7">Table7</xref>).</p><fig id="fig02" position="float"><label>FIGURE 2</label><caption><p>Forest plot shows results of the meta-analysis of rs505922 in Meta-Stroke. An inverse variance fixed effects model was used. The central filled dots represent odds ratios (ORs) in the individual cohorts, with their 95% confidence intervals (CIs; dark lines), and gray squares are proportional to sample size. The hollow diamond represents the meta-effect observed overall (p = 0.0006). ARIC = Atherosclerosis Risk in Communities; ASGC = Australian Stroke Genetics Collaborative; BRAINS = Bio- Repository of DNA in Stroke; CHS = Cardiovascular Health Study; FHS = Framingham Heart Study; GASROS = Genes Affecting Stroke Risk and Outcome Study; HPS = Heart Protection Study; HVH = Heart and Vascular Health; ISGS = Ischemic Stroke Genetics Study.</p></caption><graphic xlink:href="ana0073-0016-f2"></graphic></fig><table-wrap id="tbl5" position="float"><label>TABLE 5</label><caption><p>Characteristics of the Stroke Collections in the MetaStroke Consortium (Stage 3)</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="ana0073-0016-t5.jpg" mimetype="image"></inline-graphic></inline-formula></td></tr></tbody></table></table-wrap><table-wrap id="tbl6" position="float"><label>TABLE 6</label><caption><p>Meta-Analysis of the ABO Locus in the MetaStroke Consortium: Stage 3</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="ana0073-0016-t6.jpg" mimetype="image"></inline-graphic></inline-formula></td></tr></tbody></table></table-wrap><table-wrap id="tbl7" position="float"><label>TABLE 7</label><caption><p>Meta-Analysis of Single Nucleotide Polymorphism rs505922 in the <italic>ABO</italic> Locus by Stroke Subtype (Stage 3)</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="ana0073-0016-t7.jpg" mimetype="image"></inline-graphic></inline-formula></td></tr></tbody></table></table-wrap><p>Finally, to determine whether the genetic influence was acting through known risk factors, we performed subgroup analysis in the sample having this information, WTCCC2–Munich. Adjusting for hypertension, hypercholesterolemia, diabetes, and smoking had a small effect on the strength of the association (unadjusted: beta = 0.159, 95% CI = 0.023–0.294, <italic>p</italic> = 0.022; adjusted: beta = 0.160, 95% CI = 0.010–0.309, <italic>p</italic> = 0.036).</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Ischemic stroke accounts for considerable morbidity and mortality in Western countries, and treatment is limited at present. Our 3-stage study design optimized power for discovery of common genetic variants predisposing to ischemic stroke and stroke subtype. We performed a GWA study of intermediate coagulation and fibrinolytic phenotypes in healthy REFVIDunteers to examine the genetic determinants of end-stage coagulation and went on to study their influence on stroke and stroke subtype. We identified a large number of genetic variants associated with measures of coagulation factors, both functional and antigenic, some of which have been included in GWA meta-analyses of coagulation.<xref ref-type="bibr" rid="b23">23</xref> We confirmed that polymorphisms in the <italic>ABO</italic> gene were significantly associated with vWF and FVIII levels in healthy REFVIDunteers. Significant associations between SNPs in <italic>ABO</italic> and levels of vWF (rs505922, rs643434, rs8176743) and/or FVIII (rs505922, rs651007) were identified; we went on to demonstrate significant associations between <italic>ABO</italic> SNPs, in particular rs505922, and ischemic stroke (see forest plot in <xref ref-type="fig" rid="fig02">Fig 2</xref>).</p><p>The associations between FVIII levels and the <italic>ABO</italic> gene variant rs505922, and between <italic>ABO</italic> and coronary disease, suggest a possible mechanism behind the well-documented association between the ABO blood group and risk of vascular disorders. Non-O blood groups are at increased risk of stroke,<xref ref-type="bibr" rid="b24">24</xref> peripheral vascular disease, and myocardial infarction (MI) but not coronary artery disease (as assessed by angina, summarized by Wu et al<xref ref-type="bibr" rid="b25">25</xref>), and this suggests that end-stage coagulation is the critical determinant. The association we found with FVIII levels may account for this. Recent GWA studies of MI have identified variants within the <italic>ABO</italic> gene that predispose to MI,<xref ref-type="bibr" rid="b26">26</xref>, <xref ref-type="bibr" rid="b27">27</xref> and this relationship appears to hold for common forms of thrombotic stroke; we found evidence of association in large-vessel and cardioembolic stroke, but there was no association with small-vessel disease. At present, none of the SNPs significantly associated with stroke is reported to be associated with known risk factors such as hypertension, hyperlipidemia, diabetes, or propensity to drink alcohol or smoke. Subgroup analysis of the study group having risk factor information (WTCCC2–Munich) attenuated the strength of the association but did not suggest that the action of the genetic variation was predominantly though 1 of these risk factors.</p><p>SNP rs505922 represents a single base pair change from T to C at position 135,139,050 and lies within the first intron of the <italic>ABO</italic> gene, although its haplotype block contains the promoter and introns 1 and 2. The minor allele frequency of this SNP is 36% in Northern Europeans. The <italic>ABO</italic> gene encodes a glycosyltransferase enzyme that catalyses the transfer of different carbohydrate groups onto the H antigen, thus forming A and B antigens of the ABO system. In support of a functional role in thrombosis (as opposed to atherosclerosis), the non-O blood group has also been shown to be a risk factor for venous thrombosis,<xref ref-type="bibr" rid="b28">28</xref> and in a large prospective study, pulmonary embolism.<xref ref-type="bibr" rid="b29">29</xref> A previous GWA study identified the same SNP, rs505922, to be associated with venous thromboembolism,<xref ref-type="bibr" rid="b30">30</xref> and a recent GWA study of blood metabolites suggests that this locus may act via an effect on fibrinogen phosphorylation.<xref ref-type="bibr" rid="b31">31</xref></p><p>Our results demonstrate that the association between <italic>ABO</italic> SNPs and ischemic stroke is limited to large-artery and cardioembolic stroke, but absent in small-vessel stroke. Thromboembolism plays an important role in pathogenesis of both cardioembolic and large-artery stroke, with thrombus arising in the heart and on larger-artery atherosclerotic plaques, respectively, which may break off and embolize into the cerebral circulation. In both stroke subtypes, cerebral emboli can be detected in the cerebral circulation using transcranial Doppler,<xref ref-type="bibr" rid="b32">32</xref> and antithromboembolic therapy reduces stroke risk. Recently, vWF inhibition has been shown to reduce cerebral thromboembolism in man,<xref ref-type="bibr" rid="b33">33</xref> a clinical observation that is in keeping with our findings. In contrast, the pathogenesis of small-artery stroke is unclear, and the role of thrombosis remains uncertain.<xref ref-type="bibr" rid="b34">34</xref> Our results suggest that thrombosis may be less important for this stroke subtype and explain why antithromboembolic medication is less effective. The subtype specificity we have identified is consistent with others' results; of 5 GWA studies identified and replicated, 2 have been studies of cardioembolic stroke,<xref ref-type="bibr" rid="b35">35</xref>,<xref ref-type="bibr" rid="b36">36</xref> 2 of large-vessel stroke,<xref ref-type="bibr" rid="b37">37</xref> and 1 of small-vessel stroke.<xref ref-type="bibr" rid="b38">38</xref> Taken together, these data highlight that the clinical endpoint of ischemic stroke represents a varied phenotype likely resulting from multiple pathogenic mechanisms.</p><p>Other associations between SNPs and intermediate phenotypes included rs12137359 and FXIII activity and rs800292 and FXIIIA subunit levels. Both variants are found close to the gene encoding the FXIIIB subunit, which acts as a carrier protein for FXIIIA in the circulation and stabilizes FXIIIA to regulate activation; however, these SNPs were not associated with MI or ischemic stroke. We also identified associations between SNPs in the vicinity of the <italic>F7</italic> gene and FVII:C, consistent with a number of studies that have previously identified relationships between variation in the structural genes for FVII and circulating levels.<xref ref-type="bibr" rid="b39">39</xref>, <xref ref-type="bibr" rid="b40">40</xref> No other SNPs significantly associated with coagulation intermediate phenotypes were significantly associated with ischemic stroke.</p><p>There are a number of limitations to this work. First, TUK is predominantly female in its composition, for historical reasons. Although TUK subjects are representative of the general population variation<xref ref-type="bibr" rid="b8">8</xref> and there is no evidence of an effect of gender on the ABO predisposition to cardiovascular disease, the associations identified in Stage 1 are pertinent to females from Northern Europe. Second, the clinical studies used for Stage 2 were heterogeneous in many respects. We decided that it was of overriding importance to obtain a large sample, so we combined prospective and cross-sectional studies. One of the main strengths of the study design was the use of multiple novel intermediate phenotypes, as well as having the power to investigate stroke subtypes. The Stage 3 study groups had differing methods of genotyping and imputation, but methods have been shown to be broadly comparable.<xref ref-type="bibr" rid="b41">41</xref></p><p>In conclusion, using end-stage coagulation intermediate traits in healthy REFVIDunteers, we identified 23 genome-wide independent coagulation-associated SNPs, which were investigated in a number of clinical collections of stroke. Genetic variant rs505922 in the ABO locus was found to be associated with ischemic stroke, and in particular the subtypes large-vessel and cardioembolic stroke, but not small-vessel disease. This SNP was highly associated with vWF and FVIII in the discovery phase, and this observation throws light on possible mechanisms underlying end-stage coagulation in cardiovascular disease. It seems that common genetic variants exert some of their influence on end-stage stroke through coagulation, and further work is needed to tease apart these complex networks of interactions. The identification of the ABO locus through its association with vWF and FVIII points the way for mechanistic work to understand better the role of these 2 coagulation factors in end-stage arterial thrombosis.</p></sec></body><back><ack><p>None of the funding bodies given below played any role in the design, writing, or decision to publish this article.</p><p>TwinsUK acknowledges the Wellcome Trust funding of TwinsUK as well as Intermediate Fellow F.M.K.W., EU Framework 6 support for funding EuroCLOT (QLRT-2001-01254), and genotyping by Wellcome Trust Sanger Centre and Sequenom/Gemini genomics, Cambridge. TwinsUK is also supported by an National Institute of Health Research (NIHR) Biomedical Resource Centre grant to Guy's and St Thomas' National Health Service (NHS) Foundation Trust and King's College London. M. Boothby and J. Surr from The Division of Cardiovascular and Diabetes Research in Leeds, United Kingdom are thanked for their contributions to this program of work. The principal funding for the WTCCC2 stroke study was provided by the Wellcome Trust, as part of the WTCCC2 project (085475/B/08/Z, 085475/Z/08/Z, and WT084724MA).</p><p>For MORGAM, we thank M. Suvela and A. Vikman for MassARRAY SNP genotyping, the DNA core of the National Institute for Health and Welfare for DNA sample handling, and the Wellcome Trust Sanger Centre for Metabochip genotyping.</p><p>The Stroke Association provided additional support for collection of some of the St George's, London cases. Collection of the Munich cases and data analysis were supported by the Vascular Dementia Research Foundation. The Oxford cases were collected as part of the Oxford Vascular Study, which is funded by the Medical Research Council, Stroke Association, Dunhill Medical Trust, NIHR, and the NIHR Biomedical Research Centre, Oxford. The Edinburgh Stroke Study was supported by the Wellcome Trust (clinician scientist award to C.S.) and the Binks Trust. Sample processing occurred in the Genetics Core Laboratory of the Wellcome Trust Clinical Research Facility, Western General Hospital, Edinburgh. Much of the neuroimaging occurred at the Scottish Funding Council Brain Imaging Research Centre (<ext-link ext-link-type="uri" xlink:href="http://www.sbirc.ed.ac.uk">http://www.sbirc.ed.ac.uk</ext-link>), Division of Clinical Neurosciences, University of Edinburgh, a core area of the Wellcome Trust Clinical Research Facility and part of the SINAPSE (Scottish Imaging Network–A Platform for Scientific Excellence) collaboration (<ext-link ext-link-type="uri" xlink:href="http://www.sinapse.ac.uk">http://www.sinapse.ac.uk</ext-link>), funded by the Scottish Funding Council and the Chief Scientist Office.</p><p>The MORGAM component of this research was in part funded through the European Community's Seventh Framework Programme (FP7/2007-2013), ENGAGE project, grant agreement HEALTH-F4-2007-201413. K.Si. has been supported by the Academy of Finland Center of Excellence in Complex Disease Genetics. MORGAM thanks K. Kaliva and T. Tuovinen for help with statistical analyses and K. Kristiansson, who processed and assessed the Metabochip data.</p><p>Grant support was provided by the Wellcome Trust (grant number 098051 to A.P.); Academy of Finland (grant number 251704 to A.P.); Academy of Finland, Center of Excellence in Complex Disease Genetics (grant numbers 213506 and 129680 to A.P.); European Community's Seventh Framework Program (FP7/2007-2013), ENGAGE Consortium (grant agreement HEALTH-F4-2007-201413); EU/SYNSYS-Synaptic Systems (grant number 242167 to A.P.); and Sigrid Juselius Foundation, Finland (to A.P.).</p><p>The Heart and Vascular Health study research was supported by NIH National Heart, Lung, and Blood Institute (NHLBI) grants R01 HL085251 and R01 HL073410.</p><p>The Atherosclerosis Risk in Communities Study was carried out as a collaborative study supported by NHLBI contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C) and grants (R01HL087641, R01HL59367, and R01HL086694); National Human Genome Research Institute contract U01HG004402; and NIH contract HHSN268200625226C. Infrastructure was partly supported by grant number UL1RR025005, a component of the NIH and NIH Roadmap for Medical Research. Atherosclerosis Risk in Communities analyses performed as part of the MetaStroke project were supported by grant HL093029 to M.Fa. The REFAUs thank the staff and participants of the Atherosclerosis Risk in Communities study for their important contributions.</p><p>The Australian Stroke Genetics Collaborative (ASGC) GWAS was funded by grants from the Australian National and Medical Health Research Council (NHMRC Project Grant ID: 569257), the Australian National Heart Foundation (NHF Project Grant ID: G 04S 1623), the University of Newcastle, the Gladys M Brawn Fellowship scheme and the Vincent Fairfax Family Foundation in Australia. Australian population control data was derived from the Hunter Community Study. We thank the University of Newcastle for funding and the men and women of the Hunter region who participated in this study. EGH is supported by the Australian NHMRC Fellowship scheme.</p><p>Bio-Repository of DNA in Stroke (BRAINS) is an international study recruiting highly phenotyped patients with stroke. For the purposes of the current work, all patients were Caucasians. Diagnosis of stroke was confirmed using positive imaging (MR imaging or CT). BRAINS is partly funded by a Senior Fellowship from the UK Department of Health to Dr Pankaj Sharma, the Henry Smith Charity, and the UK–India Education Research Institutive from the British Council.</p><p>The Besta Cerebrovascular Diseases Registry (CEDIR) was supported by the Italian Ministry of Health, years 2007-2010 (Annual Research Funding; Grant Numbers: RC 2007/LR6, RC 2008/LR6; RC 2009/LR8; RC 2010/LR8). Controls for CEDIR were provided by PROCARDIS, which acknowledges support from EC FP6 (LSHM-CT-2007-037273) and AstraZeneca AB. M.Fa. is supported by the British Heart Foundation Centre for Research Excellence. A.He. was supported by an Intermediate Fellowship award from the Oxford BHF Centre for Research Excellence. M.Fe. acknowledges support from the Wellcome Trust core award to the Wellcome Trust Centre for Human Genetics (075491/Z/04 and 090532/Z09/Z).</p><p>Cardiovascular Health Study research was supported by NHLBI contracts N01-HC-85239, N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, and N01-HC-45133 and NHLBI grants HL080295, HL075366, HL087652, and HL105756, with an additional contribution from the NIH National Institute of Neurological Disorders and Stroke (NINDS). Additional support was provided through AG-023629, AG-15928, AG-20098, and AG-027058 from the NIH National Institute on Aging (NIA). See also <ext-link ext-link-type="uri" xlink:href="http://www.chs-nhlbi.org/pi.htm">http://www.chs-nhlbi.org/pi.htm</ext-link>. DNA handling and genotyping were supported in part by National Center for Research Resources Clinical and Translational Sciences Institute grant UL 1RR033176 and National Institute of Diabetes and Digestive and Kidney Diseases grant DK063491 to the Southern California Diabetes Endocrinology Research Center.</p><p>Framingham Heart Study research was supported by NHLBI contracts N01-HC-25195 and N02-HL-6-4278; and NINDS (NS17950), NHLBI (HL093029) and NIA (AG08122, AG16495, AG033193, AG031287).</p><p>The Genetics of Early Onset Stroke Study was supported by the National Institutes of Health Genes, Environment, and Health Initiative (GEI) grant U01 HG004436, as part of the GENEVA consortium under GEI, with additional support provided by the Mid-Atlantic Nutrition and Obesity Research Center (P30 DK072488); and the Office of Research and Development, Medical Research Service, and Baltimore Geriatrics Research, Education, and Clinical Center of the Department of Veterans Affairs. Genotyping services were provided by the Johns Hopkins University Center for Inherited Disease Research, which is fully funded through a federal contract from the NIH to Johns Hopkins University (contract HHSN268200782096C). Assistance with data cleaning was provided by the GENEVA Coordinating Center (U01 HG 004446; principal investigator, Bruce S. Weir). Study recruitment and collection of datasets were supported by a Cooperative Agreement with the Division of Adult and Community Health, Centers for Disease Control and by grants from the NINDS and the NIH Office of Research on Women's Health (R01 NS45012 and U01 NS069208-01).</p><p>The Ischemic Stroke Genetics Study (ISGS) and Siblings With Ischemic Stroke Study (SWISS) were supported in part by the Intramural Research Program of the NIA, NIH project Z01 AG-000954-06. ISGS/SWISS used samples and clinical data from the NIH-NINDS Human Genetics Resource Center DNA and Cell Line Repository (<ext-link ext-link-type="uri" xlink:href="http://ccr.coriell.org/ninds">http://ccr.coriell.org/ninds</ext-link> ), human subjects protocol numbers 2003-081 and 2004-147. ISGS/SWISS used stroke-free participants from the Baltimore Longitudinal Study of Aging (BLSA) as controls. The inclusion of BLSA samples was supported in part by the Intramural Research Program of the NIA, NIH project Z01 AG-000015-50, human subjects protocol number 2003-078. The ISGS study was funded by NIH-NINDS grant R01 NS-42733 (J.M.). The SWISS study was funded by NIH-NINDS grant R01 NS-39987 (J.M.). This study used the high-performance computational capabilities of the Biowulf Linux cluster at the NIH (<ext-link ext-link-type="uri" xlink:href="http://biowulf.nih.gov">http://biowulf.nih.gov</ext-link>).</p><p>The Massachusetts General Hospital Genes Affecting Stroke Risk and Outcome study was supported by grant number U01NS069208 from the NINDS. The content is solely the responsibility of the REFAUs and does not necessarily represent the official views of the NINDS or the NIH. Additional funding was provided by the American Heart Association/Bugher Foundation Centers for Stroke Prevention Research.</p><p>Rotterdam Study: The generation and management of GWAS genotype data for the Rotterdam Study is supported by the Netherlands Organisation of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) project nr. 050-060-810, Erasmus Medical Center and Erasmus University Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), the Municipality of Rotterdam, and the Netherlands Heart Foundation (Nederlandse Hartstichting) 2009B102.</p><p>Nicole Soranzo's team is supported by the Wellcome Trust (Grant Codes WT098051 and WT091310), the EU FP7 (EPIGENESYS Grant Code 257082 and BLUEPRINT Grant Code HEALTH-F5-2011-282510). C.L. and E.G.H. received funding from the Australian National Health and Medical Research Council (project grant 569257).</p><p>The EuroCLOT consortium thanks all the twin pairs who gave up their time to contribute to this study, and the staff of the NIHR BRC TwinsUK BioResource, King's College London. The Edinburgh Stroke Study component of the WTCCC2 ischaemic stroke GWAS wishes to thank Drs C. Jackson (study coordination); M. Dennis, P. Sandercock, C. Warlow, S. Hart, and S. Keir (patient recruitment and characterization); Dr J. Wardlaw, A. Farrall, and G. Potter (neuroimaging interpretation); A. Hutchison and M. McDowall (programming and database support); L. Foley (genetics laboratory management); and the patients and caregivers who took part. We thank all the participants of the MORGAM project. The Heart Protection Study thanks J. C. Hopewell, J. Armitage, S. Parish, and R. Collins for assistance. We thank the staff and participants of the Atherosclerosis Risk in Communities study for their important contributions.</p></ack><sec><title>Authorship</title><p>A.M.C. and P.G.H. contributed jointly to the work.</p><p><bold>Potential Conflicts of Interest</bold></p><p>F.M.K.W.: grants/grants pending, Wellcome Trust Fellowship 2007-12. M.D.: board membership, Boehringer Ingelheim, Ever Pharma; consultancy, Bayer Vital, Boehringer Ingelheim, Biol Heilmittel Heel, Bristol-Myers Squibb; grants/grants pending, EU FP7, DFG/DLR, Fondation Leducq, Vasc. Dem. Res. Foundation, Jackstaedt Foundation, Corona Foundation; paid manuscript preparation, Georg Thieme Verlag, UpToDate, W. Kohlhammer Verlag. P.A.: board membership, Fondation Plan Alzheimer; consultancy, Servier, Total, Alzprotect; grants/grants pending, Ipsen, Sanofi-Aventis, AstraZeneca; stock/stock options, Genoscreen. P.-G.W.: board membership, Boehringer-Ingelheim. K.St.: board membership, stock/stock options, DeCODE Genetics. B.P.: Yale University, Service on Steering Committee for YODA funded by Medtronic; University of San Francisco, Service on DSMB for a clinical trial funded by Zoll LifeCor. Y.-C.C.: grants/grants pending, US Department of Veterans Affairs.</p></sec><app-group><app id="app1"><title>Appendix</title><sec><title>Membership of Wellcome Trust Case Control Consortium 2</title><sec><title>Management Committee</title><p>Peter Donnelly (Chair), Wellcome Trust Centre for Human Genetics and Department of Statistics, University of Oxford, Oxford, United Kingdom; Ines Barroso (Deputy Chair), Wellcome Trust Genome Campus, Cambridge, United Kingdom; Jenefer M. Blackwell, Telethon Institute for Child Health Research, Child Health Research, University of Western Australia, Subiaco, Australia and Cambridge Institute for Medical Research, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom; Elvira Bramon, Department of Psychosis Studies, NIHR Biomedical Research Centre for Mental Health at the Institute of Psychiatry, King's College London and the South London and Maudsley NHS Foundation Trust, London, United Kingdom; Matthew A. Brown, University of Queensland Diamantina Institute, Brisbane, Australia; Juan P. Casas, Department Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Department of Epidemiology and Public Health, University College London, London, United Kingdom; Aiden Corvin, Neuropsychiatric Genetics Research Group, Institute of Molecular Medicine, Trinity College Dublin, Dublin, Ireland; Panos Deloukas, Wellcome Trust Genome Campus, Cambridge, United Kingdom; Audrey Duncanson, Molecular and Physiological Sciences, Wellcome Trust, London, United Kingdom; Janusz Jankowski, Department of Oncology, University of Oxford; Digestive Diseases Centre, Leicester Royal Infirmary, Leicester; and Centre for Digestive Diseases, Queen Mary University of London, London, United Kingdom; Hugh S. Markus, Stroke and Dementia Research Centre, St George's University of London, London, United Kingdom; Christopher G. Mathew, Department of Medical and Molecular Genetics, King's College London, King's Health Partners, and Guy's Hospital, London, United Kingdom; Colin N. A. Palmer, Biomedical Research Centre, Ninewells Hospital and Medical School, Dundee, United Kingdom; Robert Plomin, King's College London Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, London, United Kingdom; Anna Rautanen, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom; Stephen J. Sawcer, University of Cambridge Dept Clinical Neurosciences, Addenbrooke's Hospital, Cambridge, United Kingdom; Richard C. Trembath, Department of Medical and Molecular Genetics, King's College London, King's Health Partners, and Guy's Hospital, London, United Kingdom; Ananth C. Viswanathan, NIHR Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital NHS Foundation Trust, and UCL Institute of Ophthalmology, London, United Kingdom; and Nicholas W. Wood, Department of Molecular Neuroscience, Institute of Neurology, London, United Kingdom.</p></sec><sec><title>Data and Analysis Group</title><p>Chris C. A. Spencer, Gavin Band, Céline Bellenguez, Colin Freeman, Garrett Hellenthal, Eleni Giannoulatou, Matti Pirinen, Richard Pearson, Amy Strange, Zhan Su, and Damjan Vukcevic, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom; and Peter Donnelly, Wellcome Trust Centre for Human Genetics and Department of Statistics, University of Oxford, Oxford, United Kingdom.</p></sec><sec><title>DNA, Genotyping, Data Quality Control, and Informatics Group</title><p>Cordelia Langford, Sarah E. Hunt, Sarah Edkins, Rhian Gwilliam, Hannah Blackburn, Suzannah J. Bumpstead, Serge Dronov, Matthew Gillman, Emma Gray, Naomi Hammond, Alagurevathi Jayakumar, Owen T. McCann, Jennifer Liddle, Simon C. Potter, Radhi Ravindrarajah, Michelle Ricketts, Matthew Waller, Paul Weston, Sara Widaa, Pamela Whittaker, Ines Barroso, and Panos Deloukas, Wellcome Trust Genome Campus, Cambridge, United Kingdom.</p></sec><sec><title>Publications Committee</title><p>Christopher G. Mathew (Chair), Department of Medical and Molecular Genetics, King's College London, King's Health Partners, and Guy's Hospital, London, United Kingdom; Jenefer M. Blackwell, Telethon Institute for Child Health Research, Child Health Research, University of Western Australia, Subiaco, Australia and Cambridge Institute for Medical Research, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom; Matthew A. Brown, University of Queensland Diamantina Institute, Brisbane, Australia; Aiden Corvin, Neuropsychiatric Genetics Research Group, Institute of Molecular Medicine, Trinity College Dublin, Dublin, Ireland; and Chris C. A. Spencer, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.</p></sec></sec></app></app-group><ref-list><title>REFERENCES</title><ref id="b1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez</surname><given-names>AD</given-names></name><name><surname>Mathers</surname><given-names>CD</given-names></name><name><surname>Ezzati</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data</article-title><source>Lancet</source><year>2006</year><volume>367</volume><fpage>1747</fpage><lpage>1757</lpage><pub-id pub-id-type="pmid">16731270</pub-id></element-citation></ref><ref id="b2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Souto</surname><given-names>JC</given-names></name><name><surname>Almasy</surname><given-names>L</given-names></name><name><surname>Borrell</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia</article-title><source>Am J Hum Genet</source><year>2000</year><volume>67</volume><fpage>1452</fpage><lpage>1459</lpage><pub-id pub-id-type="pmid">11038326</pub-id></element-citation></ref><ref id="b3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>AM</given-names></name><name><surname>Cymbalista</surname><given-names>CM</given-names></name><name><surname>Spector</surname><given-names>TD</given-names></name><name><surname>Grant</surname><given-names>PJ</given-names></name></person-group><article-title>Heritability of clot formation, morphology, and lysis. The EuroCLOT study</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2007</year><volume>27</volume><fpage>2783</fpage><lpage>2789</lpage><pub-id pub-id-type="pmid">17932316</pub-id></element-citation></ref><ref id="b4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>FM</given-names></name><name><surname>Carter</surname><given-names>AM</given-names></name><name><surname>Kato</surname><given-names>B</given-names></name><etal></etal></person-group><article-title>Identification of quantitative trait loci for fibrin clot phenotypes: the EuroCLOT study</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2009</year><volume>29</volume><fpage>600</fpage><lpage>605</lpage><pub-id pub-id-type="pmid">19150881</pub-id></element-citation></ref><ref id="b5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samani</surname><given-names>NJ</given-names></name><name><surname>Erdmann</surname><given-names>J</given-names></name><name><surname>Hall</surname><given-names>AS</given-names></name><etal></etal></person-group><article-title>Genomewide association analysis of coronary artery disease</article-title><source>N Engl J Med</source><year>2007</year><volume>357</volume><fpage>443</fpage><lpage>453</lpage><pub-id pub-id-type="pmid">17634449</pub-id></element-citation></ref><ref id="b6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manolio</surname><given-names>TA</given-names></name></person-group><article-title>Collaborative genome-wide association studies of diverse diseases: programs of the NHGRI's office of population genomics</article-title><source>Pharmacogenomics</source><year>2009</year><volume>10</volume><fpage>235</fpage><lpage>241</lpage><pub-id pub-id-type="pmid">19207024</pub-id></element-citation></ref><ref id="b7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spector</surname><given-names>TD</given-names></name><name><surname>Williams</surname><given-names>FM</given-names></name></person-group><article-title>The UK Adult Twin Registry (TwinsUK)</article-title><source>Twin Res Hum Genet</source><year>2006</year><volume>9</volume><fpage>899</fpage><lpage>906</lpage><pub-id pub-id-type="pmid">17254428</pub-id></element-citation></ref><ref id="b8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrew</surname><given-names>T</given-names></name><name><surname>Hart</surname><given-names>DJ</given-names></name><name><surname>Snieder</surname><given-names>H</given-names></name><etal></etal></person-group><article-title>Are twins and singletons comparable? A study of disease-related and lifestyle characteristics in adult women</article-title><source>Twin Res</source><year>2001</year><volume>4</volume><fpage>464</fpage><lpage>477</lpage><pub-id pub-id-type="pmid">11780939</pub-id></element-citation></ref><ref id="b9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>AM</given-names></name><name><surname>Catto</surname><given-names>AJ</given-names></name><name><surname>Mansfield</surname><given-names>MW</given-names></name><etal></etal></person-group><article-title>Predictive variables for mortality after acute ischemic stroke</article-title><source>Stroke</source><year>2007</year><volume>38</volume><fpage>1873</fpage><lpage>1880</lpage><pub-id pub-id-type="pmid">17446429</pub-id></element-citation></ref><ref id="b10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Lange</surname><given-names>M</given-names></name><name><surname>Snieder</surname><given-names>H</given-names></name><name><surname>Ariens</surname><given-names>RA</given-names></name><etal></etal></person-group><article-title>The genetics of haemostasis: a twin study</article-title><source>Lancet</source><year>2001</year><volume>357</volume><fpage>101</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">11197396</pub-id></element-citation></ref><ref id="b11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>MS</given-names></name><name><surname>Mansfield</surname><given-names>MW</given-names></name><name><surname>Barrett</surname><given-names>JH</given-names></name><name><surname>Grant</surname><given-names>PJ</given-names></name></person-group><article-title>Genetic contribution to circulating levels of hemostatic factors in healthy families with effects of known genetic polymorphisms on heritability</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2002</year><volume>22</volume><fpage>506</fpage><lpage>510</lpage><pub-id pub-id-type="pmid">11884298</pub-id></element-citation></ref><ref id="b12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>MS</given-names></name><name><surname>Mansfield</surname><given-names>MW</given-names></name><name><surname>Barrett</surname><given-names>JH</given-names></name><name><surname>Grant</surname><given-names>PJ</given-names></name></person-group><article-title>Heritability of features of the insulin resistance syndrome in a community-based study of healthy families</article-title><source>Diabet Med</source><year>2002</year><volume>19</volume><fpage>994</fpage><lpage>999</lpage><pub-id pub-id-type="pmid">12647839</pub-id></element-citation></ref><ref id="b13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>A</given-names></name><name><surname>Salomaa</surname><given-names>V</given-names></name><name><surname>Kulathinal</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>MORGAM (an international pooling of cardiovascular cohorts)</article-title><source>Int J Epidemiol</source><year>2005</year><volume>34</volume><fpage>21</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">15561751</pub-id></element-citation></ref><ref id="b14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulathinal</surname><given-names>S</given-names></name><name><surname>Karvanen</surname><given-names>J</given-names></name><name><surname>Saarela</surname><given-names>O</given-names></name><name><surname>Kuulasmaa</surname><given-names>K</given-names></name></person-group><article-title>Case-cohort design in practice—experiences from the MORGAM Project</article-title><source>Epidemiol Perspect Innov</source><year>2007</year><volume>4</volume><fpage>15</fpage><pub-id pub-id-type="pmid">18053196</pub-id></element-citation></ref><ref id="b15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>HP</given-names><suffix>Jr</suffix></name><name><surname>Bendixen</surname><given-names>BH</given-names></name><name><surname>Kappelle</surname><given-names>LJ</given-names></name><etal></etal></person-group><article-title>Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment</article-title><source>Stroke</source><year>1993</year><volume>24</volume><fpage>35</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">7678184</pub-id></element-citation></ref><ref id="b16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellenguez</surname><given-names>C</given-names></name><name><surname>Bevan</surname><given-names>S</given-names></name><name><surname>Gschwendtner</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke</article-title><source>Nat Genet</source><year>2012</year><volume>44</volume><fpage>328</fpage><lpage>333</lpage><pub-id pub-id-type="pmid">22306652</pub-id></element-citation></ref><ref id="b17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hysi</surname><given-names>PG</given-names></name><name><surname>Young</surname><given-names>TL</given-names></name><name><surname>Mackey</surname><given-names>DA</given-names></name><etal></etal></person-group><article-title>A genome-wide association study for myopia and refractive error identifies a susceptibility locus at 15q25</article-title><source>Nat Genet</source><year>2010</year><volume>42</volume><fpage>902</fpage><lpage>905</lpage><pub-id pub-id-type="pmid">20835236</pub-id></element-citation></ref><ref id="b18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchini</surname><given-names>J</given-names></name><name><surname>Howie</surname><given-names>B</given-names></name><name><surname>Myers</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>A new multipoint method for genome-wide association studies by imputation of genotypes</article-title><source>Nat Genet</source><year>2007</year><volume>39</volume><fpage>906</fpage><lpage>913</lpage><pub-id pub-id-type="pmid">17572673</pub-id></element-citation></ref><ref id="b19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silander</surname><given-names>K</given-names></name><name><surname>Alanne</surname><given-names>M</given-names></name><name><surname>Kristiansson</surname><given-names>K</given-names></name><etal></etal></person-group><article-title>Gender differences in genetic risk profiles for cardiovascular disease</article-title><source>PLoS One</source><year>2008</year><volume>3</volume><fpage>e3615</fpage><pub-id pub-id-type="pmid">18974842</pub-id></element-citation></ref><ref id="b20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purcell</surname><given-names>S</given-names></name><name><surname>Neale</surname><given-names>B</given-names></name><name><surname>Todd-Brown</surname><given-names>K</given-names></name><etal></etal></person-group><article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses</article-title><source>Am J Hum Genet</source><year>2007</year><volume>81</volume><fpage>559</fpage><lpage>575</lpage><pub-id pub-id-type="pmid">17701901</pub-id></element-citation></ref><ref id="b21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willer</surname><given-names>CJ</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name></person-group><article-title>METAL: fast and efficient meta-analysis of genomewide association scans</article-title><source>Bioinformatics</source><year>2010</year><volume>26</volume><fpage>2190</fpage><lpage>2191</lpage><pub-id pub-id-type="pmid">20616382</pub-id></element-citation></ref><ref id="b22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Cherny</surname><given-names>SS</given-names></name><name><surname>Cookson</surname><given-names>WO</given-names></name><name><surname>Cardon</surname><given-names>LR</given-names></name></person-group><article-title>Merlin—rapid analysis of dense genetic maps using sparse gene flow trees</article-title><source>Nat Genet</source><year>2002</year><volume>30</volume><fpage>97</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">11731797</pub-id></element-citation></ref><ref id="b23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>NL</given-names></name><name><surname>Chen</surname><given-names>MH</given-names></name><name><surname>Dehghan</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: the CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium</article-title><source>Circulation</source><year>2010</year><volume>121</volume><fpage>1382</fpage><lpage>1392</lpage><pub-id pub-id-type="pmid">20231535</pub-id></element-citation></ref><ref id="b24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ionescu</surname><given-names>DA</given-names></name><name><surname>Marcu</surname><given-names>I</given-names></name><name><surname>Bicescu</surname><given-names>E</given-names></name></person-group><article-title>Cerebral thrombosis, cerebral haemorrhage, and ABO blood-groups</article-title><source>Lancet</source><year>1976</year><volume>1</volume><fpage>278</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">55589</pub-id></element-citation></ref><ref id="b25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>O</given-names></name><name><surname>Bayoumi</surname><given-names>N</given-names></name><name><surname>Vickers</surname><given-names>MA</given-names></name><name><surname>Clark</surname><given-names>P</given-names></name></person-group><article-title>ABO(H) blood groups and vascular disease: a systematic review and meta-analysis</article-title><source>J Thromb Haemost</source><year>2008</year><volume>6</volume><fpage>62</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">17973651</pub-id></element-citation></ref><ref id="b26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reilly</surname><given-names>MP</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>He</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies</article-title><source>Lancet</source><year>2011</year><volume>377</volume><fpage>383</fpage><lpage>392</lpage><pub-id pub-id-type="pmid">21239051</pub-id></element-citation></ref><ref id="b27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schunkert</surname><given-names>H</given-names></name><name><surname>Konig</surname><given-names>IR</given-names></name><name><surname>Kathiresan</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease</article-title><source>Nat Genet</source><year>2011</year><volume>43</volume><fpage>333</fpage><lpage>338</lpage><pub-id pub-id-type="pmid">21378990</pub-id></element-citation></ref><ref id="b28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiggins</surname><given-names>KL</given-names></name><name><surname>Smith</surname><given-names>NL</given-names></name><name><surname>Glazer</surname><given-names>NL</given-names></name><etal></etal></person-group><article-title>ABO genotype and risk of thrombotic events and hemorrhagic stroke</article-title><source>J Thromb Haemost</source><year>2009</year><volume>7</volume><fpage>263</fpage><lpage>269</lpage><pub-id pub-id-type="pmid">19036074</pub-id></element-citation></ref><ref id="b29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolpin</surname><given-names>BM</given-names></name><name><surname>Kabrhel</surname><given-names>C</given-names></name><name><surname>Varraso</surname><given-names>R</given-names></name><etal></etal></person-group><article-title>Prospective study of ABO blood type and the risk of pulmonary embolism in two large cohort studies</article-title><source>Thromb Haemost</source><year>2010</year><volume>104</volume><fpage>962</fpage><lpage>971</lpage><pub-id pub-id-type="pmid">20886188</pub-id></element-citation></ref><ref id="b30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tregouet</surname><given-names>DA</given-names></name><name><surname>Heath</surname><given-names>S</given-names></name><name><surname>Saut</surname><given-names>N</given-names></name><etal></etal></person-group><article-title>Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach</article-title><source>Blood</source><year>2009</year><volume>113</volume><fpage>5298</fpage><lpage>5303</lpage><pub-id pub-id-type="pmid">19278955</pub-id></element-citation></ref><ref id="b31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suhre</surname><given-names>K</given-names></name><name><surname>Shin</surname><given-names>SY</given-names></name><name><surname>Petersen</surname><given-names>AK</given-names></name><etal></etal></person-group><article-title>Human metabolic individuality in biomedical and pharmaceutical research</article-title><source>Nature</source><year>2011</year><volume>477</volume><fpage>54</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">21886157</pub-id></element-citation></ref><ref id="b32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>A</given-names></name><name><surname>Markus</surname><given-names>HS</given-names></name></person-group><article-title>Doppler embolic signals in cerebrovascular disease and prediction of stroke risk: a systematic review and meta-analysis</article-title><source>Stroke</source><year>2009</year><volume>40</volume><fpage>3711</fpage><lpage>3717</lpage><pub-id pub-id-type="pmid">19850894</pub-id></element-citation></ref><ref id="b33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markus</surname><given-names>HS</given-names></name><name><surname>McCollum</surname><given-names>C</given-names></name><name><surname>Imray</surname><given-names>C</given-names></name><etal></etal></person-group><article-title>The von Willebrand inhibitor ARC1779 reduces cerebral embolization after carotid endarterectomy: a randomized trial</article-title><source>Stroke</source><year>2011</year><volume>42</volume><fpage>2149</fpage><lpage>2153</lpage><pub-id pub-id-type="pmid">21700934</pub-id></element-citation></ref><ref id="b34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pantoni</surname><given-names>L</given-names></name></person-group><article-title>Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges</article-title><source>Lancet Neurol</source><year>2010</year><volume>9</volume><fpage>689</fpage><lpage>701</lpage><pub-id pub-id-type="pmid">20610345</pub-id></element-citation></ref><ref id="b35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gretarsdottir</surname><given-names>S</given-names></name><name><surname>Thorleifsson</surname><given-names>G</given-names></name><name><surname>Manolescu</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke</article-title><source>Ann Neurol</source><year>2008</year><volume>64</volume><fpage>402</fpage><lpage>409</lpage><pub-id pub-id-type="pmid">18991354</pub-id></element-citation></ref><ref id="b36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gudbjartsson</surname><given-names>DF</given-names></name><name><surname>Holm</surname><given-names>H</given-names></name><name><surname>Gretarsdottir</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke</article-title><source>Nat Genet</source><year>2009</year><volume>41</volume><fpage>876</fpage><lpage>878</lpage><pub-id pub-id-type="pmid">19597491</pub-id></element-citation></ref><ref id="b37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gschwendtner</surname><given-names>A</given-names></name><name><surname>Bevan</surname><given-names>S</given-names></name><name><surname>Cole</surname><given-names>JW</given-names></name><etal></etal></person-group><article-title>Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke</article-title><source>Ann Neurol</source><year>2009</year><volume>65</volume><fpage>531</fpage><lpage>539</lpage><pub-id pub-id-type="pmid">19475673</pub-id></element-citation></ref><ref id="b38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubo</surname><given-names>M</given-names></name><name><surname>Hata</surname><given-names>J</given-names></name><name><surname>Ninomiya</surname><given-names>T</given-names></name><etal></etal></person-group><article-title>A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction</article-title><source>Nat Genet</source><year>2007</year><volume>39</volume><fpage>212</fpage><lpage>217</lpage><pub-id pub-id-type="pmid">17206144</pub-id></element-citation></ref><ref id="b39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernardi</surname><given-names>F</given-names></name><name><surname>Arcieri</surname><given-names>P</given-names></name><name><surname>Bertina</surname><given-names>RM</given-names></name><etal></etal></person-group><article-title>Contribution of factor VII genotype to activated FVII levels. Differences in genotype frequencies between northern and southern European populations</article-title><source>Arterioscler Thromb Vasc Biol</source><year>1997</year><volume>17</volume><fpage>2548</fpage><lpage>2553</lpage><pub-id pub-id-type="pmid">9409226</pub-id></element-citation></ref><ref id="b40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calafell</surname><given-names>F</given-names></name><name><surname>Almasy</surname><given-names>L</given-names></name><name><surname>Sabater-Lleal</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Sequence variation and genetic eREFVIDution at the human F12 locus: mapping quantitative trait nucleotides that influence FXII plasma levels</article-title><source>Hum Mol Genet</source><year>2010</year><volume>19</volume><fpage>517</fpage><lpage>525</lpage><pub-id pub-id-type="pmid">19933701</pub-id></element-citation></ref><ref id="b41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nothnagel</surname><given-names>M</given-names></name><name><surname>Ellinghaus</surname><given-names>D</given-names></name><name><surname>Schreiber</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>A comprehensive evaluation of SNP genotype imputation</article-title><source>Hum Genet</source><year>2009</year><volume>125</volume><fpage>163</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">19089453</pub-id></element-citation></ref></ref-list><sec sec-type="supplementary-material"><title>Supplementary material</title><p>Additional supporting information can be found in the online version of this article.</p><supplementary-material content-type="local-data" id="SD1"><media xlink:href="ana0073-0016-SD1.doc" xlink:type="simple" id="d35e3072" position="anchor" mimetype="application" mime-subtype="msword"></media></supplementary-material></sec></back></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002239 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 002239 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.33. |  |